# Cisco timeline entity: /record/cisco.md id: ent_cisco ## undated - undated | fiscal_year_end | 07-31 | valid | [clm_440DDBB68B42](/claim/clm_440DDBB68B42.md) - undated | sic_industry | Computer Communications Equipment (3576) | valid | [clm_45E0EE6B7FD6](/claim/clm_45E0EE6B7FD6.md) - undated | listed_on | Nasdaq | valid | [clm_896AEFA6B964](/claim/clm_896AEFA6B964.md) - undated | cik | 0000858877 | valid | [clm_B971D33F6FB7](/claim/clm_B971D33F6FB7.md) - undated | state_of_incorporation | DE | valid | [clm_CCD3D83CB32E](/claim/clm_CCD3D83CB32E.md) - undated | ticker | CSCO | valid | [clm_F187956B2563](/claim/clm_F187956B2563.md) - undated | industry | networking hardware | unverified | [clm_16BA60CDC359](/claim/clm_16BA60CDC359.md) - undated | short_name | Cisco | unverified | [clm_406518A50D35](/claim/clm_406518A50D35.md) - undated | website | https://www.cisco.com/ | unverified | [clm_716CEEBA46E6](/claim/clm_716CEEBA46E6.md) - undated | country | United States | unverified | [clm_748EB1826247](/claim/clm_748EB1826247.md) - undated | legal_form | Delaware corporation | unverified | [clm_74C6D74209C5](/claim/clm_74C6D74209C5.md) - undated | linkedin | CiscoSystems | unverified | [clm_75FA4DE1EE20](/claim/clm_75FA4DE1EE20.md) - undated | member_of | [World Wide Web Consortium](/record/w3c.md) | unverified | [clm_7F10C6484931](/claim/clm_7F10C6484931.md) - undated | official_name | Cisco Systems, Inc. | unverified | [clm_9BA60210A532](/claim/clm_9BA60210A532.md) - undated | member_of | [Linux Foundation](/record/linux-foundation.md) | unverified | [clm_CBA505AF9BD1](/claim/clm_CBA505AF9BD1.md) - undated | industry | infrastructure platform | unverified | [clm_D40D3470E0B6](/claim/clm_D40D3470E0B6.md) - undated | member_of | Wi-Fi Alliance | unverified | [clm_DC83E480F58F](/claim/clm_DC83E480F58F.md) - undated | member_of | CVE Numbering Authority | unverified | [clm_EA4987840AEA](/claim/clm_EA4987840AEA.md) - undated | member_of | Wireless Power Consortium | unverified | [clm_EA919111A8ED](/claim/clm_EA919111A8ED.md) - undated | member_of | ANGA | unverified | [clm_F605F14AB7BF](/claim/clm_F605F14AB7BF.md) ## 1995 - 1995-01-01 to 2015-01-01 | ceo | John Chambers | superseded | [clm_E116CF8D179A](/claim/clm_E116CF8D179A.md) - 1995-02-13 | registrant_name | CISCO SYSTEMS, INC. | valid | [clm_3BA8D54EB795](/claim/clm_3BA8D54EB795.md) ## 2003 - 2003-07-01 to 2023-12-01 | board_member | Roderick C. McGeary | superseded | [clm_68AEC3EFD9D0](/claim/clm_68AEC3EFD9D0.md) - 2003-11-01 to 2023-12-01 | board_member | M. Michele Burns | superseded | [clm_C1EE0FA23109](/claim/clm_C1EE0FA23109.md) ## 2007 - 2007-07-28 to 2008-07-26 | cash_and_equivalents | 3,728,000,000 United States dollar | superseded | [clm_370A0279BC79](/claim/clm_370A0279BC79.md) - 2007-07-29 to 2008-07-26 | net_income | 8,052,000,000 United States dollar | superseded | [clm_16E7326E6109](/claim/clm_16E7326E6109.md) - 2007-07-29 to 2008-07-26 | revenue | 39,540,000,000 United States dollar | superseded | [clm_26EF4060612D](/claim/clm_26EF4060612D.md) - 2007-07-29 to 2008-07-26 | operating_income | 9,442,000,000 United States dollar | superseded | [clm_A7C2BB7A722C](/claim/clm_A7C2BB7A722C.md) ## 2008 - 2008-05-19 | x_username | CiscoPress | unverified | [clm_B604ACDBB7F5](/claim/clm_B604ACDBB7F5.md) - 2008-05-27 | x_username | CiscoLive | unverified | [clm_2A5128B28FB9](/claim/clm_2A5128B28FB9.md) - 2008-06-04 | x_username | ciscoDC | unverified | [clm_F335DA2CE7FF](/claim/clm_F335DA2CE7FF.md) - 2008-07-01 | x_username | CiscoIT | unverified | [clm_54993B5B6784](/claim/clm_54993B5B6784.md) - 2008-07-26 to 2008-07-27 | revenue | 39,540,000,000 United States dollar | superseded | [clm_09506F55CDEC](/claim/clm_09506F55CDEC.md) - 2008-07-26 to 2008-10-25 | cash_and_equivalents | 5,191,000,000 United States dollar | superseded | [clm_182574B1134E](/claim/clm_182574B1134E.md) - 2008-07-26 to 2008-07-27 | net_income | 8,052,000,000 United States dollar | superseded | [clm_84B2F8353C62](/claim/clm_84B2F8353C62.md) - 2008-07-26 to 2008-07-27 | operating_income | 9,442,000,000 United States dollar | superseded | [clm_F283241EFED8](/claim/clm_F283241EFED8.md) - 2008-07-27 to 2009-07-25 | revenue | 36,117,000,000 United States dollar | superseded | [clm_1F0EDA871448](/claim/clm_1F0EDA871448.md) - 2008-07-27 to 2009-07-25 | net_income | 6,134,000,000 United States dollar | superseded | [clm_5D3DB07DD550](/claim/clm_5D3DB07DD550.md) - 2008-07-27 to 2009-07-25 | operating_income | 7,322,000,000 United States dollar | superseded | [clm_6DAEC5F8B0C4](/claim/clm_6DAEC5F8B0C4.md) - 2008-08-06 | x_username | Cisco | unverified | [clm_9B07256B040C](/claim/clm_9B07256B040C.md) - 2008-08-15 | x_username | CiscoCollab | unverified | [clm_300CCF89FE65](/claim/clm_300CCF89FE65.md) - 2008-09-06 | x_username | LearningatCisco | unverified | [clm_247487D97913](/claim/clm_247487D97913.md) - 2008-09-09 | x_username | CiscoSecure | unverified | [clm_3672EC420D1C](/claim/clm_3672EC420D1C.md) - 2008-10-17 | x_username | CiscoPartners | unverified | [clm_BC0A3ECC193B](/claim/clm_BC0A3ECC193B.md) - 2008-10-25 to 2009-01-24 | quarterly_revenue | 10,331,000,000 United States dollar | superseded | [clm_1231F5604DA0](/claim/clm_1231F5604DA0.md) - 2008-10-25 to 2009-01-24 | quarterly_operating_income | 2,482,000,000 United States dollar | superseded | [clm_61EB252FF764](/claim/clm_61EB252FF764.md) - 2008-10-25 to 2009-01-24 | cash_and_equivalents | 4,197,000,000 United States dollar | superseded | [clm_A0409E948150](/claim/clm_A0409E948150.md) - 2008-10-25 to 2009-01-24 | quarterly_net_income | 2,201,000,000 United States dollar | superseded | [clm_B5FF72DD1A91](/claim/clm_B5FF72DD1A91.md) ## 2009 - 2009-01-24 to 2009-04-25 | quarterly_net_income | 1,504,000,000 United States dollar | superseded | [clm_45DBD2FCC7C6](/claim/clm_45DBD2FCC7C6.md) - 2009-01-24 to 2009-04-25 | quarterly_operating_income | 1,773,000,000 United States dollar | superseded | [clm_6C78CBF2CF72](/claim/clm_6C78CBF2CF72.md) - 2009-01-24 to 2009-04-25 | cash_and_equivalents | 4,175,000,000 United States dollar | superseded | [clm_78099C03801A](/claim/clm_78099C03801A.md) - 2009-01-24 to 2009-04-25 | quarterly_revenue | 9,089,000,000 United States dollar | superseded | [clm_E2CFC4CCDA1D](/claim/clm_E2CFC4CCDA1D.md) - 2009-02-01 | x_username | Cisco_Germany | unverified | [clm_845A73487363](/claim/clm_845A73487363.md) - 2009-02-19 | x_username | CiscoNetAcad | unverified | [clm_D787D6884FFB](/claim/clm_D787D6884FFB.md) - 2009-04-14 | x_username | CiscoNetworking | unverified | [clm_62CFF9DAE193](/claim/clm_62CFF9DAE193.md) - 2009-04-25 to 2009-10-24 | quarterly_operating_income | 1,607,000,000 United States dollar | superseded | [clm_8E8C9A26D707](/claim/clm_8E8C9A26D707.md) - 2009-04-25 to 2009-10-24 | quarterly_net_income | 1,348,000,000 United States dollar | superseded | [clm_9F74DC0162A5](/claim/clm_9F74DC0162A5.md) - 2009-04-25 to 2009-10-24 | quarterly_revenue | 8,162,000,000 United States dollar | superseded | [clm_D26F660C0065](/claim/clm_D26F660C0065.md) - 2009-04-25 to 2009-07-25 | cash_and_equivalents | 7,359,000,000 United States dollar | superseded | [clm_DA8945BBFD8E](/claim/clm_DA8945BBFD8E.md) - 2009-07-25 to 2009-10-24 | cash_and_equivalents | 5,718,000,000 United States dollar | superseded | [clm_325782AB4F39](/claim/clm_325782AB4F39.md) - 2009-07-25 to 2009-07-26 | net_income | 6,134,000,000 United States dollar | superseded | [clm_55FA98747928](/claim/clm_55FA98747928.md) - 2009-07-25 to 2009-07-26 | revenue | 36,117,000,000 United States dollar | superseded | [clm_9A17E2C8FE0B](/claim/clm_9A17E2C8FE0B.md) - 2009-07-25 to 2009-07-26 | operating_income | 7,322,000,000 United States dollar | superseded | [clm_ACD1049799CF](/claim/clm_ACD1049799CF.md) - 2009-07-25 to 2009-10-24 | total_equity | 38,647,000,000 United States dollar | superseded | [clm_ADAB16AF3541](/claim/clm_ADAB16AF3541.md) - 2009-07-25 to 2009-10-24 | total_assets | 68,128,000,000 United States dollar | superseded | [clm_F592DD3DDDC0](/claim/clm_F592DD3DDDC0.md) - 2009-07-26 to 2010-07-31 | operating_income | 9,164,000,000 United States dollar | superseded | [clm_8F74BF705F27](/claim/clm_8F74BF705F27.md) - 2009-07-26 to 2010-07-31 | net_income | 7,767,000,000 United States dollar | superseded | [clm_BC7C505E44C9](/claim/clm_BC7C505E44C9.md) - 2009-07-26 to 2010-07-31 | revenue | 40,040,000,000 United States dollar | superseded | [clm_DFD09843C68A](/claim/clm_DFD09843C68A.md) - 2009-09-08 | x_username | CiscoCX | unverified | [clm_BEB7766DABF7](/claim/clm_BEB7766DABF7.md) - 2009-10-24 to 2010-01-23 | quarterly_net_income | 1,787,000,000 United States dollar | superseded | [clm_12AEFD420FB7](/claim/clm_12AEFD420FB7.md) - 2009-10-24 to 2010-01-23 | total_equity | 40,002,000,000 United States dollar | superseded | [clm_3027B6D773AB](/claim/clm_3027B6D773AB.md) - 2009-10-24 to 2010-01-23 | total_assets | 68,680,000,000 United States dollar | superseded | [clm_35A1C202132B](/claim/clm_35A1C202132B.md) - 2009-10-24 to 2010-01-23 | cash_and_equivalents | 4,774,000,000 United States dollar | superseded | [clm_3EA3D1291C25](/claim/clm_3EA3D1291C25.md) - 2009-10-24 to 2010-01-23 | quarterly_revenue | 9,021,000,000 United States dollar | superseded | [clm_B0F138FD37E6](/claim/clm_B0F138FD37E6.md) - 2009-10-24 to 2010-01-23 | quarterly_operating_income | 2,124,000,000 United States dollar | superseded | [clm_DC8200881D3E](/claim/clm_DC8200881D3E.md) - 2009-11-12 to 2010-02-11 | shares_outstanding | 5,752,585,247 shares | superseded | [clm_75C9A07F18F9](/claim/clm_75C9A07F18F9.md) ## 2010 - 2010-01-23 to 2010-05-01 | quarterly_net_income | 1,853,000,000 United States dollar | superseded | [clm_2F003E6D7003](/claim/clm_2F003E6D7003.md) - 2010-01-23 to 2010-05-01 | cash_and_equivalents | 4,710,000,000 United States dollar | superseded | [clm_72989CBB6C6C](/claim/clm_72989CBB6C6C.md) - 2010-01-23 to 2010-05-01 | total_assets | 76,403,000,000 United States dollar | superseded | [clm_8D1FF0F664B9](/claim/clm_8D1FF0F664B9.md) - 2010-01-23 to 2010-05-01 | total_equity | 41,512,000,000 United States dollar | superseded | [clm_8F8C32DDA587](/claim/clm_8F8C32DDA587.md) - 2010-01-23 to 2010-05-01 | quarterly_operating_income | 2,370,000,000 United States dollar | superseded | [clm_A57C67CFE99D](/claim/clm_A57C67CFE99D.md) - 2010-01-23 to 2010-05-01 | quarterly_revenue | 9,815,000,000 United States dollar | superseded | [clm_DC099A49EBC5](/claim/clm_DC099A49EBC5.md) - 2010-02-11 to 2010-05-20 | shares_outstanding | 5,725,636,151 shares | superseded | [clm_637403BFEDB3](/claim/clm_637403BFEDB3.md) - 2010-05-01 to 2010-10-30 | quarterly_operating_income | 2,345,000,000 United States dollar | superseded | [clm_3F6498F88BFD](/claim/clm_3F6498F88BFD.md) - 2010-05-01 to 2010-10-30 | quarterly_revenue | 10,368,000,000 United States dollar | superseded | [clm_6CB5BAB5BC2C](/claim/clm_6CB5BAB5BC2C.md) - 2010-05-01 to 2010-10-30 | quarterly_net_income | 2,192,000,000 United States dollar | superseded | [clm_7D79C70718E9](/claim/clm_7D79C70718E9.md) - 2010-05-01 to 2010-07-31 | total_equity | 43,830,000,000 United States dollar | superseded | [clm_978884B39A89](/claim/clm_978884B39A89.md) - 2010-05-01 to 2010-07-31 | cash_and_equivalents | 3,961,000,000 United States dollar | superseded | [clm_A14D36E2E472](/claim/clm_A14D36E2E472.md) - 2010-05-01 to 2010-07-31 | total_assets | 79,292,000,000 United States dollar | superseded | [clm_AA445B7DB36C](/claim/clm_AA445B7DB36C.md) - 2010-05-20 to 2010-09-15 | shares_outstanding | 5,711,151,107 shares | superseded | [clm_DF7B9360156C](/claim/clm_DF7B9360156C.md) - 2010-07-31 to 2010-10-30 | cash_and_equivalents | 4,581,000,000 United States dollar | superseded | [clm_02AAFFC14818](/claim/clm_02AAFFC14818.md) - 2010-07-31 to 2011-07-30 | revenue | 40,040,000,000 United States dollar | superseded | [clm_57C817BA40C4](/claim/clm_57C817BA40C4.md) - 2010-07-31 to 2010-08-01 | operating_income | 9,164,000,000 United States dollar | superseded | [clm_72F1A1E451E8](/claim/clm_72F1A1E451E8.md) - 2010-07-31 to 2010-10-30 | total_assets | 81,130,000,000 United States dollar | superseded | [clm_838A64281B2E](/claim/clm_838A64281B2E.md) - 2010-07-31 to 2010-08-01 | net_income | 7,767,000,000 United States dollar | superseded | [clm_CE89E264E27E](/claim/clm_CE89E264E27E.md) - 2010-07-31 to 2010-10-30 | total_equity | 44,267,000,000 United States dollar | superseded | [clm_D30CE24F9BDB](/claim/clm_D30CE24F9BDB.md) - 2010-08-01 to 2011-07-30 | net_income | 6,490,000,000 United States dollar | superseded | [clm_771AB7D68249](/claim/clm_771AB7D68249.md) - 2010-08-01 to 2011-07-30 | operating_income | 7,674,000,000 United States dollar | superseded | [clm_ABD7C8F8A320](/claim/clm_ABD7C8F8A320.md) - 2010-09-15 to 2010-11-18 | shares_outstanding | 5,585,268,740 shares | superseded | [clm_8E568ED44450](/claim/clm_8E568ED44450.md) - 2010-10-30 to 2011-01-29 | quarterly_revenue | 10,750,000,000 United States dollar | superseded | [clm_34DB0F74AE22](/claim/clm_34DB0F74AE22.md) - 2010-10-30 to 2011-01-29 | quarterly_net_income | 1,930,000,000 United States dollar | superseded | [clm_52EC20DEF76C](/claim/clm_52EC20DEF76C.md) - 2010-10-30 to 2011-01-29 | cash_and_equivalents | 3,796,000,000 United States dollar | superseded | [clm_73BAE9F21000](/claim/clm_73BAE9F21000.md) - 2010-10-30 to 2011-01-29 | total_equity | 44,675,000,000 United States dollar | superseded | [clm_9A173BBD6431](/claim/clm_9A173BBD6431.md) - 2010-10-30 to 2011-01-29 | quarterly_operating_income | 2,351,000,000 United States dollar | superseded | [clm_D793357076BC](/claim/clm_D793357076BC.md) - 2010-10-30 to 2011-01-29 | total_assets | 80,015,000,000 United States dollar | superseded | [clm_F936722285E3](/claim/clm_F936722285E3.md) - 2010-11-01 | x_username | HeyCisco | unverified | [clm_A98F32D8A2FB](/claim/clm_A98F32D8A2FB.md) - 2010-11-18 to 2011-02-17 | shares_outstanding | 5,542,761,641 shares | superseded | [clm_AD9E4B240444](/claim/clm_AD9E4B240444.md) ## 2011 - 2011-01-29 to 2011-04-30 | total_assets | 81,981,000,000 United States dollar | superseded | [clm_25337676F9B0](/claim/clm_25337676F9B0.md) - 2011-01-29 to 2011-04-30 | quarterly_revenue | 10,407,000,000 United States dollar | superseded | [clm_40C9721C8F0E](/claim/clm_40C9721C8F0E.md) - 2011-01-29 to 2011-04-30 | total_equity | 45,641,000,000 United States dollar | superseded | [clm_55928A2A0069](/claim/clm_55928A2A0069.md) - 2011-01-29 to 2011-04-30 | quarterly_operating_income | 1,684,000,000 United States dollar | superseded | [clm_59A3E73DB197](/claim/clm_59A3E73DB197.md) - 2011-01-29 to 2011-04-30 | cash_and_equivalents | 4,924,000,000 United States dollar | superseded | [clm_A903D3596203](/claim/clm_A903D3596203.md) - 2011-01-29 to 2011-04-30 | quarterly_net_income | 1,521,000,000 United States dollar | superseded | [clm_E9C315E110D2](/claim/clm_E9C315E110D2.md) - 2011-02-17 to 2011-05-18 | shares_outstanding | 5,527,994,846 shares | superseded | [clm_3F9B89878241](/claim/clm_3F9B89878241.md) - 2011-04-30 to 2011-10-29 | quarterly_revenue | 10,866,000,000 United States dollar | superseded | [clm_051841F38A8F](/claim/clm_051841F38A8F.md) - 2011-04-30 to 2011-07-30 | total_equity | 47,163,000,000 United States dollar | superseded | [clm_442B744FDB9B](/claim/clm_442B744FDB9B.md) - 2011-04-30 to 2011-07-30 | total_assets | 85,350,000,000 United States dollar | superseded | [clm_4BE83D2ECBDD](/claim/clm_4BE83D2ECBDD.md) - 2011-04-30 to 2011-07-30 | cash_and_equivalents | 6,635,000,000 United States dollar | superseded | [clm_7A35D328D0AE](/claim/clm_7A35D328D0AE.md) - 2011-04-30 to 2011-10-29 | quarterly_net_income | 1,807,000,000 United States dollar | superseded | [clm_8C274DCC2FBE](/claim/clm_8C274DCC2FBE.md) - 2011-04-30 to 2011-10-29 | quarterly_operating_income | 2,183,000,000 United States dollar | superseded | [clm_EA4E0837D50B](/claim/clm_EA4E0837D50B.md) - 2011-05-18 to 2011-09-08 | shares_outstanding | 5,500,184,916 shares | superseded | [clm_4F89F4174681](/claim/clm_4F89F4174681.md) - 2011-07-30 to 2011-07-31 | net_income | 6,490,000,000 United States dollar | superseded | [clm_12E0D18054E8](/claim/clm_12E0D18054E8.md) - 2011-07-30 to 2011-10-29 | cash_and_equivalents | 7,662,000,000 United States dollar | superseded | [clm_2D0AD82E1800](/claim/clm_2D0AD82E1800.md) - 2011-07-30 to 2011-07-31 | operating_income | 7,674,000,000 United States dollar | superseded | [clm_7F8ABFE0AEF0](/claim/clm_7F8ABFE0AEF0.md) - 2011-07-30 to 2011-10-29 | total_equity | 47,226,000,000 United States dollar | superseded | [clm_B54F719E00A7](/claim/clm_B54F719E00A7.md) - 2011-07-30 to 2012-07-28 | revenue | 43,218,000,000 United States dollar | superseded | [clm_B98DACD3A173](/claim/clm_B98DACD3A173.md) - 2011-07-30 to 2012-07-28 | research_and_development | 5,823,000,000 United States dollar | superseded | [clm_BC25E5DFB8AD](/claim/clm_BC25E5DFB8AD.md) - 2011-07-30 to 2011-10-29 | total_assets | 87,095,000,000 United States dollar | superseded | [clm_F442FC6D32E3](/claim/clm_F442FC6D32E3.md) - 2011-07-31 to 2012-07-28 | operating_income | 10,065,000,000 United States dollar | superseded | [clm_21693A71CA6C](/claim/clm_21693A71CA6C.md) - 2011-07-31 to 2012-07-28 | net_income | 8,041,000,000 United States dollar | superseded | [clm_988B64AAD035](/claim/clm_988B64AAD035.md) - 2011-09-08 to 2011-11-15 | shares_outstanding | 5,382,854,827 shares | superseded | [clm_FEF4B3040CFE](/claim/clm_FEF4B3040CFE.md) - 2011-10-29 to 2012-01-28 | quarterly_operating_income | 2,210,000,000 United States dollar | superseded | [clm_1A91522A2E68](/claim/clm_1A91522A2E68.md) - 2011-10-29 to 2012-01-28 | total_equity | 47,188,000,000 United States dollar | superseded | [clm_2082AEEFD2D4](/claim/clm_2082AEEFD2D4.md) - 2011-10-29 to 2012-01-28 | quarterly_revenue | 11,256,000,000 United States dollar | superseded | [clm_59FA1BFC3ABC](/claim/clm_59FA1BFC3ABC.md) - 2011-10-29 to 2012-01-28 | cash_and_equivalents | 4,747,000,000 United States dollar | superseded | [clm_BADD41204A58](/claim/clm_BADD41204A58.md) - 2011-10-29 to 2012-01-28 | total_assets | 86,964,000,000 United States dollar | superseded | [clm_BC6B40F0587A](/claim/clm_BC6B40F0587A.md) - 2011-10-29 to 2012-01-28 | quarterly_net_income | 1,777,000,000 United States dollar | superseded | [clm_DC502EA46B61](/claim/clm_DC502EA46B61.md) - 2011-11-15 to 2012-02-14 | shares_outstanding | 5,375,863,983 shares | superseded | [clm_E0D449384AF2](/claim/clm_E0D449384AF2.md) ## 2012 - 2012-01-28 to 2012-04-28 | total_equity | 49,246,000,000 United States dollar | superseded | [clm_01C14AF7BA14](/claim/clm_01C14AF7BA14.md) - 2012-01-28 to 2012-04-28 | quarterly_operating_income | 2,734,000,000 United States dollar | superseded | [clm_04702FCC7BAE](/claim/clm_04702FCC7BAE.md) - 2012-01-28 to 2012-04-28 | cash_and_equivalents | 8,561,000,000 United States dollar | superseded | [clm_46F8AE06C998](/claim/clm_46F8AE06C998.md) - 2012-01-28 to 2012-04-28 | quarterly_revenue | 11,527,000,000 United States dollar | superseded | [clm_69D6B674F61E](/claim/clm_69D6B674F61E.md) - 2012-01-28 to 2012-04-28 | quarterly_net_income | 2,182,000,000 United States dollar | superseded | [clm_928CAC20E66E](/claim/clm_928CAC20E66E.md) - 2012-01-28 to 2012-04-28 | total_assets | 89,259,000,000 United States dollar | superseded | [clm_AC950FF6F61C](/claim/clm_AC950FF6F61C.md) - 2012-02-14 to 2012-05-18 | shares_outstanding | 5,385,938,187 shares | superseded | [clm_A8A4926EA2DF](/claim/clm_A8A4926EA2DF.md) - 2012-04-28 to 2012-10-27 | quarterly_revenue | 11,588,000,000 United States dollar | superseded | [clm_105F5FA6E9AF](/claim/clm_105F5FA6E9AF.md) - 2012-04-28 to 2012-10-27 | quarterly_operating_income | 2,750,000,000 United States dollar | superseded | [clm_2309FF2B02B9](/claim/clm_2309FF2B02B9.md) - 2012-04-28 to 2012-07-28 | cash_and_equivalents | 6,461,000,000 United States dollar | superseded | [clm_7753631C2F90](/claim/clm_7753631C2F90.md) - 2012-04-28 to 2012-07-28 | total_assets | 91,154,000,000 United States dollar | superseded | [clm_B45F46A015F7](/claim/clm_B45F46A015F7.md) - 2012-04-28 to 2012-10-27 | quarterly_net_income | 2,165,000,000 United States dollar | superseded | [clm_C77FDBA1E8C8](/claim/clm_C77FDBA1E8C8.md) - 2012-04-28 to 2012-07-28 | total_equity | 51,357,000,000 United States dollar | superseded | [clm_F7EC24D1D55C](/claim/clm_F7EC24D1D55C.md) - 2012-05-18 to 2012-09-05 | shares_outstanding | 5,356,878,940 shares | superseded | [clm_AAF0CC172D73](/claim/clm_AAF0CC172D73.md) - 2012-07-28 to 2013-07-27 | revenue | 46,061,000,000 United States dollar | superseded | [clm_0559332F621C](/claim/clm_0559332F621C.md) - 2012-07-28 to 2012-10-27 | cash_and_equivalents | 9,799,000,000 United States dollar | superseded | [clm_6ABA85BF8639](/claim/clm_6ABA85BF8639.md) - 2012-07-28 to 2012-10-27 | total_assets | 91,759,000,000 United States dollar | superseded | [clm_7020967DDB3D](/claim/clm_7020967DDB3D.md) - 2012-07-28 to 2012-10-27 | total_equity | 51,286,000,000 United States dollar | superseded | [clm_BC77B1ABDC87](/claim/clm_BC77B1ABDC87.md) - 2012-07-28 to 2012-07-29 | net_income | 8,041,000,000 United States dollar | superseded | [clm_C8549BC66C62](/claim/clm_C8549BC66C62.md) - 2012-07-28 to 2013-07-27 | research_and_development | 5,488,000,000 United States dollar | superseded | [clm_E38754286320](/claim/clm_E38754286320.md) - 2012-07-28 to 2012-07-29 | operating_income | 10,065,000,000 United States dollar | superseded | [clm_FD3698590370](/claim/clm_FD3698590370.md) - 2012-07-29 to 2013-07-27 | operating_income | 11,196,000,000 United States dollar | superseded | [clm_545D82DD7BF4](/claim/clm_545D82DD7BF4.md) - 2012-07-29 to 2013-07-27 | net_income | 9,983,000,000 United States dollar | superseded | [clm_D35833F6B064](/claim/clm_D35833F6B064.md) - 2012-09-05 to 2012-11-15 | shares_outstanding | 5,290,061,557 shares | superseded | [clm_37FC893A8B14](/claim/clm_37FC893A8B14.md) - 2012-10-27 to 2013-01-26 | total_assets | 92,643,000,000 United States dollar | superseded | [clm_1688BB5242A4](/claim/clm_1688BB5242A4.md) - 2012-10-27 to 2013-01-26 | cash_and_equivalents | 4,773,000,000 United States dollar | superseded | [clm_31C842149985](/claim/clm_31C842149985.md) - 2012-10-27 to 2013-01-26 | quarterly_operating_income | 2,651,000,000 United States dollar | superseded | [clm_3FA838E73C39](/claim/clm_3FA838E73C39.md) - 2012-10-27 to 2013-01-26 | total_equity | 52,686,000,000 United States dollar | superseded | [clm_62D7BD88FDA3](/claim/clm_62D7BD88FDA3.md) - 2012-10-27 to 2013-01-26 | quarterly_net_income | 2,092,000,000 United States dollar | superseded | [clm_B3D4DA7B8D0D](/claim/clm_B3D4DA7B8D0D.md) - 2012-10-27 to 2013-01-26 | quarterly_revenue | 11,876,000,000 United States dollar | superseded | [clm_C938445ACBE7](/claim/clm_C938445ACBE7.md) - 2012-11-15 to 2013-02-14 | shares_outstanding | 5,309,248,366 shares | superseded | [clm_243F763863E1](/claim/clm_243F763863E1.md) ## 2013 - 2013-01-26 to 2013-04-27 | quarterly_operating_income | 2,789,000,000 United States dollar | superseded | [clm_2E584A4B71D1](/claim/clm_2E584A4B71D1.md) - 2013-01-26 to 2013-04-27 | quarterly_net_income | 3,143,000,000 United States dollar | superseded | [clm_650884F3F3B0](/claim/clm_650884F3F3B0.md) - 2013-01-26 to 2013-04-27 | cash_and_equivalents | 6,847,000,000 United States dollar | superseded | [clm_A9D87E20E9AC](/claim/clm_A9D87E20E9AC.md) - 2013-01-26 to 2013-04-27 | quarterly_revenue | 12,098,000,000 United States dollar | superseded | [clm_BA92B2DEAF79](/claim/clm_BA92B2DEAF79.md) - 2013-01-26 to 2013-04-27 | total_equity | 55,515,000,000 United States dollar | superseded | [clm_F58BE21C11FC](/claim/clm_F58BE21C11FC.md) - 2013-01-26 to 2013-04-27 | total_assets | 96,378,000,000 United States dollar | superseded | [clm_FAF9AE3221D4](/claim/clm_FAF9AE3221D4.md) - 2013-02-14 to 2013-05-16 | shares_outstanding | 5,331,973,900 shares | superseded | [clm_63BD43C3D174](/claim/clm_63BD43C3D174.md) - 2013-04-27 to 2013-07-27 | total_equity | 56,788,000,000 United States dollar | superseded | [clm_0AFFBD2DD8D8](/claim/clm_0AFFBD2DD8D8.md) - 2013-04-27 to 2013-10-26 | quarterly_revenue | 12,216,000,000 United States dollar | superseded | [clm_177E22CF848A](/claim/clm_177E22CF848A.md) - 2013-04-27 to 2013-07-27 | total_assets | 97,084,000,000 United States dollar | superseded | [clm_2C79399D72DF](/claim/clm_2C79399D72DF.md) - 2013-04-27 to 2013-07-27 | cash_and_equivalents | 5,122,000,000 United States dollar | superseded | [clm_61AEB712F71C](/claim/clm_61AEB712F71C.md) - 2013-04-27 to 2013-10-26 | quarterly_net_income | 2,478,000,000 United States dollar | superseded | [clm_DDC7FC667E99](/claim/clm_DDC7FC667E99.md) - 2013-04-27 to 2013-10-26 | quarterly_operating_income | 2,942,000,000 United States dollar | superseded | [clm_EE8538F8A0FF](/claim/clm_EE8538F8A0FF.md) - 2013-05-16 to 2013-09-04 | shares_outstanding | 5,344,336,014 shares | superseded | [clm_91C912F4C298](/claim/clm_91C912F4C298.md) - 2013-07-27 to 2013-10-26 | cash_and_equivalents | 7,925,000,000 United States dollar | superseded | [clm_0CD3898A83D8](/claim/clm_0CD3898A83D8.md) - 2013-07-27 to 2013-07-28 | net_income | 9,983,000,000 United States dollar | superseded | [clm_10AA481722DE](/claim/clm_10AA481722DE.md) - 2013-07-27 to 2013-07-28 | operating_income | 11,196,000,000 United States dollar | superseded | [clm_3B917A600E87](/claim/clm_3B917A600E87.md) - 2013-07-27 to 2014-07-26 | research_and_development | 5,942,000,000 United States dollar | superseded | [clm_9E441C7A7F9A](/claim/clm_9E441C7A7F9A.md) - 2013-07-27 to 2013-10-26 | total_equity | 59,120,000,000 United States dollar | superseded | [clm_AA73E1CCAF03](/claim/clm_AA73E1CCAF03.md) - 2013-07-27 to 2014-07-26 | revenue | 48,607,000,000 United States dollar | superseded | [clm_C6A686D771B9](/claim/clm_C6A686D771B9.md) - 2013-07-27 to 2013-10-26 | total_assets | 101,191,000,000 United States dollar | superseded | [clm_EE68DDBB12B1](/claim/clm_EE68DDBB12B1.md) - 2013-07-28 to 2014-07-26 | operating_income | 9,345,000,000 United States dollar | superseded | [clm_23B1D3D4C58F](/claim/clm_23B1D3D4C58F.md) - 2013-07-28 to 2014-07-26 | net_income | 7,853,000,000 United States dollar | superseded | [clm_74F3692E4730](/claim/clm_74F3692E4730.md) - 2013-09-04 to 2013-11-15 | shares_outstanding | 5,361,549,877 shares | superseded | [clm_A0F24F7256F8](/claim/clm_A0F24F7256F8.md) - 2013-10-26 to 2014-01-25 | total_equity | 58,897,000,000 United States dollar | superseded | [clm_2F4DA19321C6](/claim/clm_2F4DA19321C6.md) - 2013-10-26 to 2014-01-25 | quarterly_operating_income | 2,455,000,000 United States dollar | superseded | [clm_3511DC6A71CF](/claim/clm_3511DC6A71CF.md) - 2013-10-26 to 2014-01-25 | quarterly_research_and_development | 1,724,000,000 United States dollar | superseded | [clm_6F67B937BC56](/claim/clm_6F67B937BC56.md) - 2013-10-26 to 2014-01-25 | total_assets | 100,741,000,000 United States dollar | superseded | [clm_715CD9BF0EBB](/claim/clm_715CD9BF0EBB.md) - 2013-10-26 to 2014-01-25 | cash_and_equivalents | 5,254,000,000 United States dollar | superseded | [clm_8703AB654E5B](/claim/clm_8703AB654E5B.md) - 2013-10-26 to 2014-01-25 | quarterly_revenue | 12,085,000,000 United States dollar | superseded | [clm_AC1969FC27A6](/claim/clm_AC1969FC27A6.md) - 2013-10-26 to 2014-01-25 | quarterly_net_income | 1,996,000,000 United States dollar | superseded | [clm_D6F4D3CDAC8B](/claim/clm_D6F4D3CDAC8B.md) - 2013-11-15 to 2014-02-14 | shares_outstanding | 5,346,617,505 shares | superseded | [clm_21EE1B9677EF](/claim/clm_21EE1B9677EF.md) ## 2014 - 2014-01-25 to 2014-04-26 | quarterly_operating_income | 1,667,000,000 United States dollar | superseded | [clm_086E2E8379E0](/claim/clm_086E2E8379E0.md) - 2014-01-25 to 2014-04-26 | total_equity | 56,069,000,000 United States dollar | superseded | [clm_13BCC5ACF768](/claim/clm_13BCC5ACF768.md) - 2014-01-25 to 2014-04-26 | quarterly_revenue | 11,155,000,000 United States dollar | superseded | [clm_3A4D701B46A7](/claim/clm_3A4D701B46A7.md) - 2014-01-25 to 2014-04-26 | total_assets | 98,427,000,000 United States dollar | superseded | [clm_4A17A9EA3755](/claim/clm_4A17A9EA3755.md) - 2014-01-25 to 2014-04-26 | cash_and_equivalents | 5,339,000,000 United States dollar | superseded | [clm_5BF394AEB20D](/claim/clm_5BF394AEB20D.md) - 2014-01-25 to 2014-04-26 | quarterly_research_and_development | 1,412,000,000 United States dollar | superseded | [clm_A286164A07F9](/claim/clm_A286164A07F9.md) - 2014-01-25 to 2014-04-26 | quarterly_net_income | 1,429,000,000 United States dollar | superseded | [clm_EFEE251362A5](/claim/clm_EFEE251362A5.md) - 2014-02-14 to 2014-05-16 | shares_outstanding | 5,151,281,052 shares | superseded | [clm_AFEA2295DD61](/claim/clm_AFEA2295DD61.md) - 2014-04-26 to 2014-10-25 | quarterly_operating_income | 2,542,000,000 United States dollar | superseded | [clm_5602040B0818](/claim/clm_5602040B0818.md) - 2014-04-26 to 2014-07-26 | total_equity | 55,787,000,000 United States dollar | superseded | [clm_729BECB78B14](/claim/clm_729BECB78B14.md) - 2014-04-26 to 2014-10-25 | quarterly_revenue | 11,545,000,000 United States dollar | superseded | [clm_747B4CF364AD](/claim/clm_747B4CF364AD.md) - 2014-04-26 to 2014-07-26 | total_assets | 101,856,000,000 United States dollar | superseded | [clm_79A474DD8F38](/claim/clm_79A474DD8F38.md) - 2014-04-26 to 2014-10-25 | quarterly_net_income | 2,181,000,000 United States dollar | superseded | [clm_84AA33FBE147](/claim/clm_84AA33FBE147.md) - 2014-04-26 to 2014-10-25 | quarterly_research_and_development | 1,565,000,000 United States dollar | superseded | [clm_B6EC9AAAB716](/claim/clm_B6EC9AAAB716.md) - 2014-04-26 to 2014-07-26 | cash_and_equivalents | 6,241,000,000 United States dollar | superseded | [clm_D67622EBAA7A](/claim/clm_D67622EBAA7A.md) - 2014-05-16 to 2014-09-04 | shares_outstanding | 5,122,689,670 shares | superseded | [clm_D0BF87A48AED](/claim/clm_D0BF87A48AED.md) - 2014-07-26 to 2014-10-25 | cash_and_equivalents | 6,726,000,000 United States dollar | superseded | [clm_2AC74AAA741E](/claim/clm_2AC74AAA741E.md) - 2014-07-26 to 2014-10-25 | total_equity | 56,654,000,000 United States dollar | superseded | [clm_45F6391D514F](/claim/clm_45F6391D514F.md) - 2014-07-26 to 2014-07-27 | operating_income | 9,345,000,000 United States dollar | superseded | [clm_505B4E2CE250](/claim/clm_505B4E2CE250.md) - 2014-07-26 to 2015-07-25 | research_and_development | 6,294,000,000 United States dollar | superseded | [clm_5A7787035E7E](/claim/clm_5A7787035E7E.md) - 2014-07-26 to 2014-07-27 | net_income | 7,853,000,000 United States dollar | superseded | [clm_C5AF4C8428EF](/claim/clm_C5AF4C8428EF.md) - 2014-07-26 to 2015-07-25 | revenue | 47,142,000,000 United States dollar | superseded | [clm_C91568860170](/claim/clm_C91568860170.md) - 2014-07-26 to 2014-10-25 | total_assets | 105,134,000,000 United States dollar | superseded | [clm_FA8EEF984D5C](/claim/clm_FA8EEF984D5C.md) - 2014-07-27 to 2015-07-25 | operating_income | 10,770,000,000 United States dollar | superseded | [clm_00D488F831B8](/claim/clm_00D488F831B8.md) - 2014-07-27 to 2015-07-25 | net_income | 8,981,000,000 United States dollar | superseded | [clm_2D217EB1C837](/claim/clm_2D217EB1C837.md) - 2014-09-04 to 2014-11-14 | shares_outstanding | 5,099,203,169 shares | superseded | [clm_18D2DE360CD7](/claim/clm_18D2DE360CD7.md) - 2014-10-25 to 2015-01-24 | total_assets | 103,978,000,000 United States dollar | superseded | [clm_09B81DE5ED66](/claim/clm_09B81DE5ED66.md) - 2014-10-25 to 2015-01-24 | quarterly_research_and_development | 1,583,000,000 United States dollar | superseded | [clm_18BD04B95B8F](/claim/clm_18BD04B95B8F.md) - 2014-10-25 to 2015-01-24 | total_equity | 56,708,000,000 United States dollar | superseded | [clm_6DF7B48F2E56](/claim/clm_6DF7B48F2E56.md) - 2014-10-25 to 2015-01-24 | quarterly_revenue | 12,245,000,000 United States dollar | superseded | [clm_8D95B4427D9F](/claim/clm_8D95B4427D9F.md) - 2014-10-25 to 2015-01-24 | quarterly_operating_income | 2,342,000,000 United States dollar | superseded | [clm_9C83ABF9BEE3](/claim/clm_9C83ABF9BEE3.md) - 2014-10-25 to 2015-01-24 | quarterly_net_income | 1,828,000,000 United States dollar | superseded | [clm_AC35AE09789B](/claim/clm_AC35AE09789B.md) - 2014-10-25 to 2015-01-24 | cash_and_equivalents | 4,387,000,000 United States dollar | superseded | [clm_F56BB8251DF4](/claim/clm_F56BB8251DF4.md) - 2014-11-14 to 2015-02-13 | shares_outstanding | 5,113,588,147 shares | superseded | [clm_1709D138FBB8](/claim/clm_1709D138FBB8.md) ## 2015 - 2015-01-24 to 2015-04-25 | quarterly_operating_income | 2,622,000,000 United States dollar | superseded | [clm_3F97EBD91F93](/claim/clm_3F97EBD91F93.md) - 2015-01-24 to 2015-04-25 | cash_and_equivalents | 4,797,000,000 United States dollar | superseded | [clm_7BB1BCB3A4AB](/claim/clm_7BB1BCB3A4AB.md) - 2015-01-24 to 2015-04-25 | quarterly_revenue | 11,936,000,000 United States dollar | superseded | [clm_921BA984402D](/claim/clm_921BA984402D.md) - 2015-01-24 to 2015-04-25 | total_equity | 57,718,000,000 United States dollar | superseded | [clm_A1DF8AFE56C9](/claim/clm_A1DF8AFE56C9.md) - 2015-01-24 to 2015-04-25 | quarterly_research_and_development | 1,529,000,000 United States dollar | superseded | [clm_A84FCA948F93](/claim/clm_A84FCA948F93.md) - 2015-01-24 to 2015-04-25 | quarterly_net_income | 2,397,000,000 United States dollar | superseded | [clm_E37D5888D417](/claim/clm_E37D5888D417.md) - 2015-01-24 to 2015-04-25 | total_assets | 104,922,000,000 United States dollar | superseded | [clm_F9D38113C7A1](/claim/clm_F9D38113C7A1.md) - 2015-02-13 to 2015-05-15 | shares_outstanding | 5,104,738,671 shares | superseded | [clm_FBB32896D5D6](/claim/clm_FBB32896D5D6.md) - 2015-04-25 to 2015-07-25 | total_equity | 58,823,000,000 United States dollar | superseded | [clm_2C50A7F2B2CA](/claim/clm_2C50A7F2B2CA.md) - 2015-04-25 to 2015-10-24 | quarterly_research_and_development | 1,547,000,000 United States dollar | superseded | [clm_40F035F30F1B](/claim/clm_40F035F30F1B.md) - 2015-04-25 to 2015-07-25 | total_assets | 106,212,000,000 United States dollar | superseded | [clm_5EB4DC57E652](/claim/clm_5EB4DC57E652.md) - 2015-04-25 to 2015-10-24 | quarterly_net_income | 2,437,000,000 United States dollar | superseded | [clm_76C06F82B600](/claim/clm_76C06F82B600.md) - 2015-04-25 to 2015-07-25 | cash_and_equivalents | 3,870,000,000 United States dollar | superseded | [clm_9E2142DB5552](/claim/clm_9E2142DB5552.md) - 2015-04-25 to 2015-10-24 | quarterly_revenue | 12,137,000,000 United States dollar | superseded | [clm_BB1CBB89045E](/claim/clm_BB1CBB89045E.md) - 2015-04-25 to 2015-10-24 | quarterly_operating_income | 2,925,000,000 United States dollar | superseded | [clm_E00E1CA7092C](/claim/clm_E00E1CA7092C.md) - 2015-05-15 to 2015-09-03 | shares_outstanding | 5,085,888,730 shares | superseded | [clm_43602BC705C1](/claim/clm_43602BC705C1.md) - 2015-07-01 | ceo | Chuck Robbins | unverified | [clm_D97296749768](/claim/clm_D97296749768.md) - 2015-07-25 to 2015-10-24 | total_assets | 113,481,000,000 United States dollar | superseded | [clm_1195B766BB75](/claim/clm_1195B766BB75.md) - 2015-07-25 to 2016-07-30 | revenue | 49,161,000,000 United States dollar | superseded | [clm_1726365F8317](/claim/clm_1726365F8317.md) - 2015-07-25 to 2016-07-30 | research_and_development | 6,207,000,000 United States dollar | superseded | [clm_4F40BB7EECF0](/claim/clm_4F40BB7EECF0.md) - 2015-07-25 to 2015-10-24 | total_equity | 59,698,000,000 United States dollar | superseded | [clm_64AE6BC4AF37](/claim/clm_64AE6BC4AF37.md) - 2015-07-25 to 2015-10-24 | cash_and_equivalents | 6,877,000,000 United States dollar | superseded | [clm_801307DF24D5](/claim/clm_801307DF24D5.md) - 2015-07-25 to 2015-07-26 | operating_income | 10,770,000,000 United States dollar | superseded | [clm_856E8F6DC8EC](/claim/clm_856E8F6DC8EC.md) - 2015-07-25 to 2015-07-26 | net_income | 8,981,000,000 United States dollar | superseded | [clm_B5219379A887](/claim/clm_B5219379A887.md) - 2015-07-26 to 2016-07-30 | operating_income | 12,660,000,000 United States dollar | superseded | [clm_3C7F4699EC00](/claim/clm_3C7F4699EC00.md) - 2015-07-26 to 2016-07-30 | net_income | 10,739,000,000 United States dollar | superseded | [clm_8D0AAF961E4F](/claim/clm_8D0AAF961E4F.md) - 2015-09-03 to 2015-11-13 | shares_outstanding | 5,061,293,291 shares | superseded | [clm_2302A35CB5D6](/claim/clm_2302A35CB5D6.md) - 2015-10-24 to 2016-01-23 | quarterly_research_and_development | 1,560,000,000 United States dollar | superseded | [clm_56567FFA4D1F](/claim/clm_56567FFA4D1F.md) - 2015-10-24 to 2016-01-23 | cash_and_equivalents | 5,758,000,000 United States dollar | superseded | [clm_61A1AD6E539F](/claim/clm_61A1AD6E539F.md) - 2015-10-24 to 2016-01-23 | quarterly_operating_income | 3,079,000,000 United States dollar | superseded | [clm_82E222029A40](/claim/clm_82E222029A40.md) - 2015-10-24 to 2016-01-23 | quarterly_revenue | 12,682,000,000 United States dollar | superseded | [clm_83A618775747](/claim/clm_83A618775747.md) - 2015-10-24 to 2016-01-23 | total_equity | 59,977,000,000 United States dollar | superseded | [clm_8F3E29169581](/claim/clm_8F3E29169581.md) - 2015-10-24 to 2016-01-23 | quarterly_net_income | 2,430,000,000 United States dollar | superseded | [clm_D1C4CF842E68](/claim/clm_D1C4CF842E68.md) - 2015-10-24 to 2015-12-31 | total_assets | 111,773,000,000 United States dollar | superseded | [clm_DCD98CF01A4A](/claim/clm_DCD98CF01A4A.md) - 2015-11-13 to 2016-02-12 | shares_outstanding | 5,076,079,317 shares | superseded | [clm_CFEB5B242418](/claim/clm_CFEB5B242418.md) - 2015-12-31 to 2016-01-23 | total_assets | 104,900,000,000 United States dollar | superseded | [clm_F6F7B1F2A9EB](/claim/clm_F6F7B1F2A9EB.md) ## 2016 - 2016-01-23 to 2016-04-30 | quarterly_revenue | 11,927,000,000 United States dollar | superseded | [clm_546F366BBD7A](/claim/clm_546F366BBD7A.md) - 2016-01-23 to 2016-04-30 | quarterly_operating_income | 3,294,000,000 United States dollar | superseded | [clm_6971D12B3DEE](/claim/clm_6971D12B3DEE.md) - 2016-01-23 to 2016-04-30 | quarterly_net_income | 3,147,000,000 United States dollar | superseded | [clm_79B23B501F5C](/claim/clm_79B23B501F5C.md) - 2016-01-23 to 2016-04-30 | total_assets | 112,642,000,000 United States dollar | superseded | [clm_A324AAEFE4EF](/claim/clm_A324AAEFE4EF.md) - 2016-01-23 to 2016-04-30 | quarterly_research_and_development | 1,509,000,000 United States dollar | superseded | [clm_B2FC576C2A12](/claim/clm_B2FC576C2A12.md) - 2016-01-23 to 2016-04-30 | cash_and_equivalents | 6,314,000,000 United States dollar | superseded | [clm_F088821519C8](/claim/clm_F088821519C8.md) - 2016-01-23 to 2016-04-30 | total_equity | 60,871,000,000 United States dollar | superseded | [clm_FDDCEDA4EE3F](/claim/clm_FDDCEDA4EE3F.md) - 2016-02-12 to 2016-05-19 | shares_outstanding | 5,032,121,234 shares | superseded | [clm_E5CF11A84308](/claim/clm_E5CF11A84308.md) - 2016-04-30 to 2016-07-30 | total_equity | 62,358,000,000 United States dollar | superseded | [clm_2A51C0DB96AE](/claim/clm_2A51C0DB96AE.md) - 2016-04-30 to 2016-07-30 | total_assets | 118,654,000,000 United States dollar | superseded | [clm_40438071C468](/claim/clm_40438071C468.md) - 2016-04-30 to 2016-10-29 | quarterly_net_income | 2,349,000,000 United States dollar | superseded | [clm_6AA956A7D63D](/claim/clm_6AA956A7D63D.md) - 2016-04-30 to 2016-10-29 | quarterly_operating_income | 2,984,000,000 United States dollar | superseded | [clm_7338784A3550](/claim/clm_7338784A3550.md) - 2016-04-30 to 2016-10-29 | quarterly_revenue | 12,000,000,000 United States dollar | superseded | [clm_D5001FB7EADF](/claim/clm_D5001FB7EADF.md) - 2016-04-30 to 2016-10-29 | quarterly_research_and_development | 1,626,000,000 United States dollar | superseded | [clm_D774F2E33C32](/claim/clm_D774F2E33C32.md) - 2016-04-30 to 2016-07-30 | cash_and_equivalents | 8,895,000,000 United States dollar | superseded | [clm_DD70DE161226](/claim/clm_DD70DE161226.md) - 2016-05-19 to 2016-09-02 | shares_outstanding | 5,029,711,978 shares | superseded | [clm_A40E0B488773](/claim/clm_A40E0B488773.md) - 2016-07-30 to 2017-07-29 | research_and_development | 6,296,000,000 United States dollar | superseded | [clm_3D940D85911E](/claim/clm_3D940D85911E.md) - 2016-07-30 to 2017-07-29 | revenue | 49,247,000,000 United States dollar | superseded | [clm_67F02CB7DC83](/claim/clm_67F02CB7DC83.md) - 2016-07-30 to 2016-10-29 | total_equity | 63,586,000,000 United States dollar | superseded | [clm_84637187C887](/claim/clm_84637187C887.md) - 2016-07-30 to 2016-10-29 | cash_and_equivalents | 7,631,000,000 United States dollar | superseded | [clm_9CC0C654470C](/claim/clm_9CC0C654470C.md) - 2016-07-30 to 2016-07-31 | operating_income | 12,660,000,000 United States dollar | superseded | [clm_B02121810976](/claim/clm_B02121810976.md) - 2016-07-30 to 2016-10-29 | total_assets | 121,652,000,000 United States dollar | superseded | [clm_C340DA6DF4B0](/claim/clm_C340DA6DF4B0.md) - 2016-07-30 to 2016-07-31 | net_income | 10,739,000,000 United States dollar | superseded | [clm_FF0CA0B9F88C](/claim/clm_FF0CA0B9F88C.md) - 2016-07-31 to 2017-07-29 | net_income | 9,609,000,000 United States dollar | superseded | [clm_09F4DD1F9928](/claim/clm_09F4DD1F9928.md) - 2016-07-31 to 2017-07-29 | operating_income | 11,973,000,000 United States dollar | superseded | [clm_E776029904A7](/claim/clm_E776029904A7.md) - 2016-09-02 to 2016-11-17 | shares_outstanding | 5,014,353,833 shares | superseded | [clm_FC989BF598E4](/claim/clm_FC989BF598E4.md) - 2016-10-29 to 2017-01-28 | total_assets | 126,287,000,000 United States dollar | superseded | [clm_0870E91409AD](/claim/clm_0870E91409AD.md) - 2016-10-29 to 2017-01-28 | quarterly_operating_income | 2,877,000,000 United States dollar | superseded | [clm_2BDD289F3A01](/claim/clm_2BDD289F3A01.md) - 2016-10-29 to 2017-01-28 | total_equity | 63,406,000,000 United States dollar | superseded | [clm_6F855E70C452](/claim/clm_6F855E70C452.md) - 2016-10-29 to 2017-01-28 | quarterly_net_income | 2,322,000,000 United States dollar | superseded | [clm_863957B3838C](/claim/clm_863957B3838C.md) - 2016-10-29 to 2017-01-28 | quarterly_revenue | 12,352,000,000 United States dollar | superseded | [clm_CD15CFA6CBCA](/claim/clm_CD15CFA6CBCA.md) - 2016-10-29 to 2017-01-28 | quarterly_research_and_development | 1,545,000,000 United States dollar | superseded | [clm_D2842004D1F2](/claim/clm_D2842004D1F2.md) - 2016-10-29 to 2017-01-28 | cash_and_equivalents | 8,583,000,000 United States dollar | superseded | [clm_E90A5AF4BB9D](/claim/clm_E90A5AF4BB9D.md) - 2016-11-17 to 2017-02-16 | shares_outstanding | 5,019,758,934 shares | superseded | [clm_D118923C09A9](/claim/clm_D118923C09A9.md) ## 2017 - 2017-01-28 to 2017-04-29 | quarterly_revenue | 11,580,000,000 United States dollar | superseded | [clm_294548EFB35B](/claim/clm_294548EFB35B.md) - 2017-01-28 to 2017-04-29 | quarterly_net_income | 2,348,000,000 United States dollar | superseded | [clm_2A20920F65DE](/claim/clm_2A20920F65DE.md) - 2017-01-28 to 2017-04-29 | cash_and_equivalents | 10,898,000,000 United States dollar | superseded | [clm_330AB084D5CB](/claim/clm_330AB084D5CB.md) - 2017-01-28 to 2017-04-29 | quarterly_research_and_development | 1,508,000,000 United States dollar | superseded | [clm_3D2E25183972](/claim/clm_3D2E25183972.md) - 2017-01-28 to 2017-04-29 | total_equity | 63,811,000,000 United States dollar | superseded | [clm_9E0FF8A591D3](/claim/clm_9E0FF8A591D3.md) - 2017-01-28 to 2017-04-29 | quarterly_operating_income | 2,893,000,000 United States dollar | superseded | [clm_D0E89C64037B](/claim/clm_D0E89C64037B.md) - 2017-01-28 to 2017-04-29 | total_assets | 126,248,000,000 United States dollar | superseded | [clm_F63255D1BFBB](/claim/clm_F63255D1BFBB.md) - 2017-02-16 to 2017-05-18 | shares_outstanding | 5,007,856,247 shares | superseded | [clm_5B1713C23668](/claim/clm_5B1713C23668.md) - 2017-03-01 to 2023-02-01 | board_member | Brent Saunders | superseded | [clm_94DD3FF60230](/claim/clm_94DD3FF60230.md) - 2017-04-29 to 2017-07-29 | total_equity | 65,382,000,000 United States dollar | superseded | [clm_2D5CBF578089](/claim/clm_2D5CBF578089.md) - 2017-04-29 to 2017-10-28 | quarterly_operating_income | 3,169,000,000 United States dollar | superseded | [clm_3D456EA9E9AC](/claim/clm_3D456EA9E9AC.md) - 2017-04-29 to 2017-07-29 | total_assets | 125,950,000,000 United States dollar | superseded | [clm_85066B960010](/claim/clm_85066B960010.md) - 2017-04-29 to 2017-07-29 | cash_and_equivalents | 8,116,000,000 United States dollar | superseded | [clm_B9462EFCA745](/claim/clm_B9462EFCA745.md) - 2017-04-29 to 2017-10-28 | quarterly_research_and_development | 1,507,000,000 United States dollar | superseded | [clm_E7DDF1EC3D40](/claim/clm_E7DDF1EC3D40.md) - 2017-04-29 to 2017-10-28 | quarterly_net_income | 2,515,000,000 United States dollar | superseded | [clm_F4495D374023](/claim/clm_F4495D374023.md) - 2017-04-29 to 2017-10-28 | quarterly_revenue | 11,940,000,000 United States dollar | superseded | [clm_F839250DE4D1](/claim/clm_F839250DE4D1.md) - 2017-05-18 to 2017-09-01 | shares_outstanding | 5,000,054,399 shares | superseded | [clm_F4AC07D3963B](/claim/clm_F4AC07D3963B.md) - 2017-07-29 to 2018-07-28 | research_and_development | 6,059,000,000 United States dollar | superseded | [clm_12A1A3E8D22C](/claim/clm_12A1A3E8D22C.md) - 2017-07-29 to 2018-07-28 | revenue | 48,005,000,000 United States dollar | superseded | [clm_2DD30842916D](/claim/clm_2DD30842916D.md) - 2017-07-29 to 2017-10-28 | total_equity | 66,137,000,000 United States dollar | superseded | [clm_367C71724D58](/claim/clm_367C71724D58.md) - 2017-07-29 to 2017-07-30 | operating_income | 11,973,000,000 United States dollar | superseded | [clm_3E393AA71785](/claim/clm_3E393AA71785.md) - 2017-07-29 to 2017-10-28 | cash_and_equivalents | 11,708,000,000 United States dollar | superseded | [clm_53594B042514](/claim/clm_53594B042514.md) - 2017-07-29 to 2017-10-28 | total_assets | 129,818,000,000 United States dollar | superseded | [clm_68EA3903068A](/claim/clm_68EA3903068A.md) - 2017-07-29 to 2017-07-30 | net_income | 9,609,000,000 United States dollar | superseded | [clm_7EEEE046AA5F](/claim/clm_7EEEE046AA5F.md) - 2017-07-30 to 2018-07-28 | operating_income | 12,309,000,000 United States dollar | superseded | [clm_361486618415](/claim/clm_361486618415.md) - 2017-07-30 to 2018-07-28 | net_income | 110,000,000 United States dollar | superseded | [clm_BB39014CAE78](/claim/clm_BB39014CAE78.md) - 2017-09-01 to 2017-11-16 | shares_outstanding | 4,951,955,851 shares | superseded | [clm_EE66E7EB1EFC](/claim/clm_EE66E7EB1EFC.md) - 2017-10-28 to 2018-01-27 | total_assets | 130,522,000,000 United States dollar | superseded | [clm_0118546E0AB2](/claim/clm_0118546E0AB2.md) - 2017-10-28 to 2018-01-27 | quarterly_net_income | 2,394,000,000 United States dollar | superseded | [clm_2E24DDE671E9](/claim/clm_2E24DDE671E9.md) - 2017-10-28 to 2018-01-27 | quarterly_operating_income | 2,756,000,000 United States dollar | superseded | [clm_34F41C75AF9F](/claim/clm_34F41C75AF9F.md) - 2017-10-28 to 2018-01-27 | cash_and_equivalents | 11,043,000,000 United States dollar | superseded | [clm_3670D5F3C9AD](/claim/clm_3670D5F3C9AD.md) - 2017-10-28 to 2018-01-27 | total_equity | 65,550,000,000 United States dollar | superseded | [clm_7C76838BE8AA](/claim/clm_7C76838BE8AA.md) - 2017-10-28 to 2018-01-27 | quarterly_research_and_development | 1,567,000,000 United States dollar | superseded | [clm_9442604C0073](/claim/clm_9442604C0073.md) - 2017-10-28 to 2018-01-27 | quarterly_revenue | 12,136,000,000 United States dollar | superseded | [clm_BA7F4EB3529B](/claim/clm_BA7F4EB3529B.md) - 2017-11-16 to 2018-02-15 | shares_outstanding | 4,943,622,124 shares | superseded | [clm_ECCEECA3BBB6](/claim/clm_ECCEECA3BBB6.md) ## 2018 - 2018-01-27 to 2018-04-28 | quarterly_revenue | 11,887,000,000 United States dollar | superseded | [clm_10B502A941C5](/claim/clm_10B502A941C5.md) - 2018-01-27 to 2018-04-28 | total_assets | 131,510,000,000 United States dollar | superseded | [clm_66E8682A8058](/claim/clm_66E8682A8058.md) - 2018-01-27 to 2018-04-28 | total_equity | 51,982,000,000 United States dollar | superseded | [clm_78DBF252DD74](/claim/clm_78DBF252DD74.md) - 2018-01-27 to 2018-04-28 | cash_and_equivalents | 17,624,000,000 United States dollar | superseded | [clm_7D01207F79F6](/claim/clm_7D01207F79F6.md) - 2018-01-27 to 2018-04-28 | quarterly_research_and_development | 1,549,000,000 United States dollar | superseded | [clm_8993EACD8F84](/claim/clm_8993EACD8F84.md) - 2018-01-27 to 2018-04-28 | quarterly_operating_income | 3,073,000,000 United States dollar | superseded | [clm_D158EF275970](/claim/clm_D158EF275970.md) - 2018-01-27 to 2018-04-28 | quarterly_net_income | -8,778,000,000 United States dollar | superseded | [clm_D4DD5FCF36DA](/claim/clm_D4DD5FCF36DA.md) - 2018-02-15 to 2018-05-17 | shares_outstanding | 4,817,517,410 shares | superseded | [clm_23292B89237A](/claim/clm_23292B89237A.md) - 2018-04-28 to 2018-10-27 | quarterly_net_income | 2,691,000,000 United States dollar | superseded | [clm_1688278A8607](/claim/clm_1688278A8607.md) - 2018-04-28 to 2018-10-27 | quarterly_research_and_development | 1,590,000,000 United States dollar | superseded | [clm_1A3A4111D57C](/claim/clm_1A3A4111D57C.md) - 2018-04-28 to 2018-07-28 | total_equity | 46,661,000,000 United States dollar | superseded | [clm_1BB72BEE1249](/claim/clm_1BB72BEE1249.md) - 2018-04-28 to 2018-07-28 | cash_and_equivalents | 6,719,000,000 United States dollar | superseded | [clm_3D9225487B8C](/claim/clm_3D9225487B8C.md) - 2018-04-28 to 2018-07-28 | total_assets | 114,008,000,000 United States dollar | superseded | [clm_600F9AF4D4EA](/claim/clm_600F9AF4D4EA.md) - 2018-04-28 to 2018-10-27 | quarterly_revenue | 12,463,000,000 United States dollar | superseded | [clm_689CF759F165](/claim/clm_689CF759F165.md) - 2018-04-28 to 2018-10-27 | quarterly_operating_income | 3,134,000,000 United States dollar | superseded | [clm_6F1451B8AC9F](/claim/clm_6F1451B8AC9F.md) - 2018-05-17 to 2018-08-31 | shares_outstanding | 4,702,882,494 shares | superseded | [clm_A474139117C3](/claim/clm_A474139117C3.md) - 2018-07-28 to 2018-07-29 | operating_income | 12,309,000,000 United States dollar | superseded | [clm_1A2D12A017D2](/claim/clm_1A2D12A017D2.md) - 2018-07-28 to 2018-10-27 | total_equity | 43,204,000,000 United States dollar | superseded | [clm_1B7F52A29EFB](/claim/clm_1B7F52A29EFB.md) - 2018-07-28 to 2018-10-27 | cash_and_equivalents | 8,934,000,000 United States dollar | superseded | [clm_3A8248392366](/claim/clm_3A8248392366.md) - 2018-07-28 to 2019-07-27 | revenue | 49,330,000,000 United States dollar | superseded | [clm_5D35D8CD87F4](/claim/clm_5D35D8CD87F4.md) - 2018-07-28 to 2018-07-29 | net_income | 110,000,000 United States dollar | superseded | [clm_F3ACA27DC5AE](/claim/clm_F3ACA27DC5AE.md) - 2018-07-28 to 2019-07-27 | research_and_development | 6,332,000,000 United States dollar | superseded | [clm_FA7D42DA0C84](/claim/clm_FA7D42DA0C84.md) - 2018-07-29 to 2019-07-27 | operating_income | 14,219,000,000 United States dollar | superseded | [clm_425CCD66A8C9](/claim/clm_425CCD66A8C9.md) - 2018-07-29 to 2018-10-27 | total_assets | 109,872,000,000 United States dollar | superseded | [clm_4E7227E63A72](/claim/clm_4E7227E63A72.md) - 2018-07-29 to 2019-07-27 | net_income | 11,621,000,000 United States dollar | superseded | [clm_ED1E5CEE0C9C](/claim/clm_ED1E5CEE0C9C.md) - 2018-08-31 to 2018-11-15 | shares_outstanding | 4,571,334,136 shares | superseded | [clm_CFCCA29A3CF6](/claim/clm_CFCCA29A3CF6.md) - 2018-10-27 to 2019-01-26 | quarterly_research_and_development | 1,608,000,000 United States dollar | superseded | [clm_1B9354FC0504](/claim/clm_1B9354FC0504.md) - 2018-10-27 to 2019-01-26 | quarterly_revenue | 13,072,000,000 United States dollar | superseded | [clm_2A6EEDF18377](/claim/clm_2A6EEDF18377.md) - 2018-10-27 to 2019-01-26 | quarterly_net_income | 3,549,000,000 United States dollar | superseded | [clm_4CFECA53C3AE](/claim/clm_4CFECA53C3AE.md) - 2018-10-27 to 2019-01-26 | quarterly_operating_income | 3,805,000,000 United States dollar | superseded | [clm_9298EB80617D](/claim/clm_9298EB80617D.md) - 2018-10-27 to 2019-01-26 | total_assets | 105,429,000,000 United States dollar | superseded | [clm_9BB017528C15](/claim/clm_9BB017528C15.md) - 2018-10-27 to 2019-01-26 | total_equity | 43,848,000,000 United States dollar | superseded | [clm_B03B4DE5BBAE](/claim/clm_B03B4DE5BBAE.md) - 2018-10-27 to 2019-01-26 | cash_and_equivalents | 8,410,000,000 United States dollar | superseded | [clm_F434E0AF60B0](/claim/clm_F434E0AF60B0.md) - 2018-11-15 to 2019-02-14 | shares_outstanding | 4,495,961,730 shares | superseded | [clm_FA138F532CB8](/claim/clm_FA138F532CB8.md) ## 2019 - 2019-01-26 to 2019-04-27 | quarterly_operating_income | 3,211,000,000 United States dollar | superseded | [clm_356DE81A99C7](/claim/clm_356DE81A99C7.md) - 2019-01-26 to 2019-04-27 | total_equity | 40,789,000,000 United States dollar | superseded | [clm_6086D528F7C5](/claim/clm_6086D528F7C5.md) - 2019-01-26 to 2019-04-27 | quarterly_net_income | 2,822,000,000 United States dollar | superseded | [clm_783797F10B89](/claim/clm_783797F10B89.md) - 2019-01-26 to 2019-04-27 | quarterly_revenue | 12,446,000,000 United States dollar | superseded | [clm_8AD1DB1248EE](/claim/clm_8AD1DB1248EE.md) - 2019-01-26 to 2019-04-27 | quarterly_research_and_development | 1,557,000,000 United States dollar | superseded | [clm_9D9DE446DC34](/claim/clm_9D9DE446DC34.md) - 2019-01-26 to 2019-04-27 | total_assets | 102,462,000,000 United States dollar | superseded | [clm_BF0655EB88B3](/claim/clm_BF0655EB88B3.md) - 2019-01-26 to 2019-04-27 | cash_and_equivalents | 9,835,000,000 United States dollar | superseded | [clm_F41DB851FAFD](/claim/clm_F41DB851FAFD.md) - 2019-02-14 to 2019-05-16 | shares_outstanding | 4,402,027,716 shares | superseded | [clm_8414F39B30EB](/claim/clm_8414F39B30EB.md) - 2019-04-27 to 2019-07-27 | total_equity | 36,804,000,000 United States dollar | superseded | [clm_3389D354792D](/claim/clm_3389D354792D.md) - 2019-04-27 to 2019-07-27 | total_assets | 97,287,000,000 United States dollar | superseded | [clm_8B3FBD485265](/claim/clm_8B3FBD485265.md) - 2019-04-27 to 2019-10-26 | quarterly_revenue | 12,958,000,000 United States dollar | superseded | [clm_95B161872A03](/claim/clm_95B161872A03.md) - 2019-04-27 to 2019-10-26 | quarterly_net_income | 3,044,000,000 United States dollar | superseded | [clm_A4CE9E6CDEEA](/claim/clm_A4CE9E6CDEEA.md) - 2019-04-27 to 2019-10-26 | quarterly_research_and_development | 1,659,000,000 United States dollar | superseded | [clm_BA1938E32B96](/claim/clm_BA1938E32B96.md) - 2019-04-27 to 2019-10-26 | quarterly_operating_income | 3,513,000,000 United States dollar | superseded | [clm_C62211F610D7](/claim/clm_C62211F610D7.md) - 2019-04-27 to 2019-07-27 | cash_and_equivalents | 10,251,000,000 United States dollar | superseded | [clm_D88379035390](/claim/clm_D88379035390.md) - 2019-05-01 to 2025-10-01 | board_member | Wesley Bush | superseded | [clm_5E51A1314309](/claim/clm_5E51A1314309.md) - 2019-05-16 to 2019-08-30 | shares_outstanding | 4,280,733,008 shares | superseded | [clm_5B53475AEA62](/claim/clm_5B53475AEA62.md) - 2019-07-27 to 2019-10-26 | total_assets | 97,793,000,000 United States dollar | superseded | [clm_37911DC080EB](/claim/clm_37911DC080EB.md) - 2019-07-27 to 2019-10-26 | cash_and_equivalents | 11,750,000,000 United States dollar | superseded | [clm_4BD5F9221CD6](/claim/clm_4BD5F9221CD6.md) - 2019-07-27 to 2019-07-28 | operating_income | 14,219,000,000 United States dollar | superseded | [clm_A22A4F2295EE](/claim/clm_A22A4F2295EE.md) - 2019-07-27 to 2019-07-28 | revenue | 51,904,000,000 United States dollar | superseded | [clm_BCC01DD4C3C6](/claim/clm_BCC01DD4C3C6.md) - 2019-07-27 to 2020-12-31 | employees | 75,900 | superseded | [clm_C661201189A1](/claim/clm_C661201189A1.md) - 2019-07-27 to 2019-10-26 | total_equity | 33,571,000,000 United States dollar | superseded | [clm_F261F5C2612F](/claim/clm_F261F5C2612F.md) - 2019-07-27 to 2019-07-28 | net_income | 11,621,000,000 United States dollar | superseded | [clm_F71B251A3386](/claim/clm_F71B251A3386.md) - 2019-07-27 to 2020-07-25 | research_and_development | 6,577,000,000 United States dollar | superseded | [clm_FA4F0D97A911](/claim/clm_FA4F0D97A911.md) - 2019-07-28 to 2020-07-25 | net_income | 11,214,000,000 United States dollar | superseded | [clm_88939F03A326](/claim/clm_88939F03A326.md) - 2019-07-28 to 2020-07-25 | operating_income | 13,620,000,000 United States dollar | superseded | [clm_CD79E5B579EF](/claim/clm_CD79E5B579EF.md) - 2019-07-28 to 2020-07-25 | revenue | 49,301,000,000 United States dollar | superseded | [clm_EC8085A6EC4A](/claim/clm_EC8085A6EC4A.md) - 2019-08-30 to 2019-11-14 | shares_outstanding | 4,245,290,230 shares | superseded | [clm_9DE48DA0E479](/claim/clm_9DE48DA0E479.md) - 2019-10-26 to 2020-01-25 | quarterly_revenue | 13,159,000,000 United States dollar | superseded | [clm_1E1BE593E3E1](/claim/clm_1E1BE593E3E1.md) - 2019-10-26 to 2020-01-25 | total_assets | 92,492,000,000 United States dollar | superseded | [clm_4324E980AF57](/claim/clm_4324E980AF57.md) - 2019-10-26 to 2020-01-25 | cash_and_equivalents | 8,587,000,000 United States dollar | superseded | [clm_46692E215421](/claim/clm_46692E215421.md) - 2019-10-26 to 2020-01-25 | quarterly_net_income | 2,926,000,000 United States dollar | superseded | [clm_4C9AF9F14D04](/claim/clm_4C9AF9F14D04.md) - 2019-10-26 to 2020-01-25 | total_equity | 34,423,000,000 United States dollar | superseded | [clm_73C911E002AF](/claim/clm_73C911E002AF.md) - 2019-10-26 to 2020-01-25 | quarterly_operating_income | 3,579,000,000 United States dollar | superseded | [clm_74B8C1E45AA5](/claim/clm_74B8C1E45AA5.md) - 2019-10-26 to 2020-01-25 | quarterly_research_and_development | 1,666,000,000 United States dollar | superseded | [clm_BA6E7973768B](/claim/clm_BA6E7973768B.md) - 2019-11-14 to 2020-02-13 | shares_outstanding | 4,242,262,570 shares | superseded | [clm_200B8B61F904](/claim/clm_200B8B61F904.md) ## 2020 - 2020-01-01 to 2023-12-01 | board_member | Lisa Su | superseded | [clm_1FB98021A037](/claim/clm_1FB98021A037.md) - 2020-01-25 to 2020-04-25 | total_equity | 35,533,000,000 United States dollar | superseded | [clm_0A0B3A703EF3](/claim/clm_0A0B3A703EF3.md) - 2020-01-25 to 2020-04-25 | cash_and_equivalents | 8,475,000,000 United States dollar | superseded | [clm_0E6B1A3E686E](/claim/clm_0E6B1A3E686E.md) - 2020-01-25 to 2020-04-25 | quarterly_research_and_development | 1,570,000,000 United States dollar | superseded | [clm_4B51B1F2EB7F](/claim/clm_4B51B1F2EB7F.md) - 2020-01-25 to 2020-04-25 | quarterly_revenue | 12,005,000,000 United States dollar | superseded | [clm_6A35EC7A4407](/claim/clm_6A35EC7A4407.md) - 2020-01-25 to 2020-04-25 | total_assets | 90,426,000,000 United States dollar | superseded | [clm_714C5469612E](/claim/clm_714C5469612E.md) - 2020-01-25 to 2020-04-25 | quarterly_operating_income | 3,380,000,000 United States dollar | superseded | [clm_756EA69D8DF5](/claim/clm_756EA69D8DF5.md) - 2020-01-25 to 2020-04-25 | quarterly_net_income | 2,878,000,000 United States dollar | superseded | [clm_AEEDBAD23872](/claim/clm_AEEDBAD23872.md) - 2020-02-13 to 2020-05-14 | shares_outstanding | 4,240,880,161 shares | superseded | [clm_97050F1B6CED](/claim/clm_97050F1B6CED.md) - 2020-04-25 to 2020-10-24 | quarterly_revenue | 11,983,000,000 United States dollar | superseded | [clm_21557A453610](/claim/clm_21557A453610.md) - 2020-04-25 to 2020-07-25 | total_assets | 91,394,000,000 United States dollar | superseded | [clm_2E5DB5DF92EE](/claim/clm_2E5DB5DF92EE.md) - 2020-04-25 to 2020-07-25 | total_equity | 35,708,000,000 United States dollar | superseded | [clm_6E0921D4CA9D](/claim/clm_6E0921D4CA9D.md) - 2020-04-25 to 2020-10-24 | quarterly_net_income | 2,774,000,000 United States dollar | superseded | [clm_7D6CC3FBAA81](/claim/clm_7D6CC3FBAA81.md) - 2020-04-25 to 2020-10-24 | quarterly_operating_income | 3,414,000,000 United States dollar | superseded | [clm_88A31D326C5F](/claim/clm_88A31D326C5F.md) - 2020-04-25 to 2020-10-24 | quarterly_research_and_development | 1,546,000,000 United States dollar | superseded | [clm_AAE31FA77180](/claim/clm_AAE31FA77180.md) - 2020-04-25 to 2020-07-25 | cash_and_equivalents | 10,366,000,000 United States dollar | superseded | [clm_CC2076D524D2](/claim/clm_CC2076D524D2.md) - 2020-05-14 to 2020-08-28 | shares_outstanding | 4,222,296,202 shares | superseded | [clm_F8D87974BEA9](/claim/clm_F8D87974BEA9.md) - 2020-07-25 to 2020-10-24 | total_assets | 94,853,000,000 United States dollar | superseded | [clm_33D700E5B102](/claim/clm_33D700E5B102.md) - 2020-07-25 to 2021-07-31 | operating_income | 13,620,000,000 United States dollar | superseded | [clm_3C353C196E1D](/claim/clm_3C353C196E1D.md) - 2020-07-25 to 2021-07-31 | research_and_development | 6,347,000,000 United States dollar | superseded | [clm_7AF903B897C0](/claim/clm_7AF903B897C0.md) - 2020-07-25 to 2021-07-31 | revenue | 49,301,000,000 United States dollar | superseded | [clm_8110385979EF](/claim/clm_8110385979EF.md) - 2020-07-25 to 2020-10-24 | total_equity | 37,920,000,000 United States dollar | superseded | [clm_83859CFC65BE](/claim/clm_83859CFC65BE.md) - 2020-07-25 to 2021-07-31 | net_income | 11,214,000,000 United States dollar | superseded | [clm_C818A211105E](/claim/clm_C818A211105E.md) - 2020-07-25 to 2020-10-24 | cash_and_equivalents | 11,809,000,000 United States dollar | superseded | [clm_C88378BE166F](/claim/clm_C88378BE166F.md) - 2020-08-28 to 2020-11-12 | shares_outstanding | 4,233,425,297 shares | superseded | [clm_B91B38EADD0E](/claim/clm_B91B38EADD0E.md) - 2020-10-24 to 2021-01-23 | quarterly_research_and_development | 1,612,000,000 United States dollar | superseded | [clm_02B739930235](/claim/clm_02B739930235.md) - 2020-10-24 to 2021-01-23 | quarterly_revenue | 11,929,000,000 United States dollar | superseded | [clm_528AD9EF05A0](/claim/clm_528AD9EF05A0.md) - 2020-10-24 to 2021-01-23 | total_assets | 95,003,000,000 United States dollar | superseded | [clm_58A0AA974A68](/claim/clm_58A0AA974A68.md) - 2020-10-24 to 2021-01-23 | total_equity | 38,157,000,000 United States dollar | superseded | [clm_5C60001623A6](/claim/clm_5C60001623A6.md) - 2020-10-24 to 2021-01-23 | quarterly_net_income | 2,174,000,000 United States dollar | superseded | [clm_63B33B2CA6EA](/claim/clm_63B33B2CA6EA.md) - 2020-10-24 to 2021-01-23 | cash_and_equivalents | 10,822,000,000 United States dollar | superseded | [clm_8621F9A02418](/claim/clm_8621F9A02418.md) - 2020-10-24 to 2021-01-23 | quarterly_operating_income | 2,570,000,000 United States dollar | superseded | [clm_ABB7EE97AB8B](/claim/clm_ABB7EE97AB8B.md) - 2020-11-12 to 2021-02-11 | shares_outstanding | 4,225,514,401 shares | superseded | [clm_8BDD90C6F7ED](/claim/clm_8BDD90C6F7ED.md) ## 2021 - 2021-01-23 to 2021-05-01 | quarterly_research_and_development | 1,527,000,000 United States dollar | superseded | [clm_1BBDE90C42A0](/claim/clm_1BBDE90C42A0.md) - 2021-01-23 to 2021-05-01 | cash_and_equivalents | 11,793,000,000 United States dollar | superseded | [clm_4025DEFC45EC](/claim/clm_4025DEFC45EC.md) - 2021-01-23 to 2021-05-01 | total_equity | 39,121,000,000 United States dollar | superseded | [clm_5F953E00597E](/claim/clm_5F953E00597E.md) - 2021-01-23 to 2021-05-01 | quarterly_operating_income | 3,223,000,000 United States dollar | superseded | [clm_836B6DF71CD0](/claim/clm_836B6DF71CD0.md) - 2021-01-23 to 2021-05-01 | quarterly_net_income | 2,545,000,000 United States dollar | superseded | [clm_BA4B268E553E](/claim/clm_BA4B268E553E.md) - 2021-01-23 to 2021-05-01 | quarterly_revenue | 11,960,000,000 United States dollar | superseded | [clm_DE02D4BBED6D](/claim/clm_DE02D4BBED6D.md) - 2021-01-23 to 2021-05-01 | total_assets | 95,601,000,000 United States dollar | superseded | [clm_FA78CB6779E4](/claim/clm_FA78CB6779E4.md) - 2021-02-11 to 2021-05-20 | shares_outstanding | 4,221,785,547 shares | superseded | [clm_BD37463BCFE5](/claim/clm_BD37463BCFE5.md) - 2021-05-01 to 2021-10-30 | quarterly_operating_income | 3,465,000,000 United States dollar | superseded | [clm_0B29A78A368F](/claim/clm_0B29A78A368F.md) - 2021-05-01 to 2021-10-30 | quarterly_research_and_development | 1,697,000,000 United States dollar | superseded | [clm_14E273D41254](/claim/clm_14E273D41254.md) - 2021-05-01 to 2021-07-31 | cash_and_equivalents | 7,350,000,000 United States dollar | superseded | [clm_53C1FDEFFEEA](/claim/clm_53C1FDEFFEEA.md) - 2021-05-01 to 2021-10-30 | quarterly_revenue | 12,803,000,000 United States dollar | superseded | [clm_7690E75901FE](/claim/clm_7690E75901FE.md) - 2021-05-01 to 2021-07-31 | total_equity | 40,205,000,000 United States dollar | superseded | [clm_A746FA1179AF](/claim/clm_A746FA1179AF.md) - 2021-05-01 to 2021-10-30 | quarterly_net_income | 2,863,000,000 United States dollar | superseded | [clm_B0BF284DC53B](/claim/clm_B0BF284DC53B.md) - 2021-05-01 to 2021-07-31 | total_assets | 93,896,000,000 United States dollar | superseded | [clm_DE17560F2785](/claim/clm_DE17560F2785.md) - 2021-05-20 to 2021-09-03 | shares_outstanding | 4,214,204,641 shares | superseded | [clm_F1F9B263446F](/claim/clm_F1F9B263446F.md) - 2021-07-31 to 2021-10-30 | total_equity | 41,275,000,000 United States dollar | superseded | [clm_129CA5EEA1F2](/claim/clm_129CA5EEA1F2.md) - 2021-07-31 to 2021-10-30 | total_assets | 97,497,000,000 United States dollar | superseded | [clm_2B684C6B7399](/claim/clm_2B684C6B7399.md) - 2021-07-31 to 2021-08-01 | net_income | 10,591,000,000 United States dollar | superseded | [clm_35315B13B1DB](/claim/clm_35315B13B1DB.md) - 2021-07-31 to 2021-10-30 | cash_and_equivalents | 9,175,000,000 United States dollar | superseded | [clm_37FFAC1D9E27](/claim/clm_37FFAC1D9E27.md) - 2021-07-31 to 2022-07-30 | revenue | 49,818,000,000 United States dollar | superseded | [clm_58C17710AE1E](/claim/clm_58C17710AE1E.md) - 2021-07-31 to 2025-07-26 | employees | 79,500 | superseded | [clm_5B5CF30ED6A0](/claim/clm_5B5CF30ED6A0.md) - 2021-07-31 to 2021-08-01 | operating_income | 12,833,000,000 United States dollar | superseded | [clm_7207A3A0D157](/claim/clm_7207A3A0D157.md) - 2021-07-31 to 2022-07-30 | research_and_development | 6,549,000,000 United States dollar | superseded | [clm_AD5FF1EE86F2](/claim/clm_AD5FF1EE86F2.md) - 2021-08-01 to 2021-12-31 | net_income | 11,812,000,000 United States dollar | superseded | [clm_035972958864](/claim/clm_035972958864.md) - 2021-08-01 to 2022-07-30 | operating_income | 13,969,000,000 United States dollar | superseded | [clm_B56E7D506B1A](/claim/clm_B56E7D506B1A.md) - 2021-09-03 to 2021-11-18 | shares_outstanding | 4,217,735,917 shares | superseded | [clm_69DDC4DD1913](/claim/clm_69DDC4DD1913.md) - 2021-10-30 to 2022-01-29 | cash_and_equivalents | 7,619,000,000 United States dollar | superseded | [clm_46C5551C1F71](/claim/clm_46C5551C1F71.md) - 2021-10-30 to 2022-01-29 | quarterly_net_income | 2,980,000,000 United States dollar | superseded | [clm_49239E42AC73](/claim/clm_49239E42AC73.md) - 2021-10-30 to 2022-01-29 | total_equity | 42,701,000,000 United States dollar | superseded | [clm_7A78D3EAC703](/claim/clm_7A78D3EAC703.md) - 2021-10-30 to 2022-01-29 | total_assets | 95,981,000,000 United States dollar | superseded | [clm_91E5501A9DE9](/claim/clm_91E5501A9DE9.md) - 2021-10-30 to 2022-01-29 | quarterly_research_and_development | 1,714,000,000 United States dollar | superseded | [clm_A9B138471B1C](/claim/clm_A9B138471B1C.md) - 2021-10-30 to 2022-01-29 | quarterly_revenue | 12,900,000,000 United States dollar | superseded | [clm_F20A09E2CE99](/claim/clm_F20A09E2CE99.md) - 2021-10-30 to 2022-01-29 | quarterly_operating_income | 3,438,000,000 United States dollar | superseded | [clm_FF769DE75397](/claim/clm_FF769DE75397.md) - 2021-11-18 to 2022-02-17 | shares_outstanding | 4,217,606,555 shares | superseded | [clm_21F902B46452](/claim/clm_21F902B46452.md) - 2021-12-31 to 2022-07-30 | net_income | 10,591,000,000 United States dollar | superseded | [clm_565D3CDCDDE1](/claim/clm_565D3CDCDDE1.md) ## 2022 - 2022-01-29 to 2022-04-30 | cash_and_equivalents | 6,731,000,000 United States dollar | superseded | [clm_2CCB31B49BF8](/claim/clm_2CCB31B49BF8.md) - 2022-01-29 to 2022-04-30 | total_equity | 39,496,000,000 United States dollar | superseded | [clm_2D2AAC19477D](/claim/clm_2D2AAC19477D.md) - 2022-01-29 to 2022-04-30 | quarterly_net_income | 2,973,000,000 United States dollar | superseded | [clm_404AF24C7336](/claim/clm_404AF24C7336.md) - 2022-01-29 to 2022-04-30 | quarterly_operating_income | 3,487,000,000 United States dollar | superseded | [clm_84394BB215FB](/claim/clm_84394BB215FB.md) - 2022-01-29 to 2022-04-30 | quarterly_research_and_development | 1,670,000,000 United States dollar | superseded | [clm_91734C2E1A35](/claim/clm_91734C2E1A35.md) - 2022-01-29 to 2022-04-30 | quarterly_revenue | 12,720,000,000 United States dollar | superseded | [clm_AF9CA6341942](/claim/clm_AF9CA6341942.md) - 2022-01-29 to 2022-04-30 | total_assets | 94,262,000,000 United States dollar | superseded | [clm_F61EEE51982C](/claim/clm_F61EEE51982C.md) - 2022-02-01 to 2026-05-05 | market_cap | 234,790,000,000 United States dollar | superseded | [clm_925A5F6E9B86](/claim/clm_925A5F6E9B86.md) - 2022-02-17 to 2022-05-19 | shares_outstanding | 4,154,168,000 shares | superseded | [clm_BDD589EB521A](/claim/clm_BDD589EB521A.md) - 2022-04-30 to 2022-07-30 | total_equity | 40,400,000,000 United States dollar | superseded | [clm_5B0E91B163E1](/claim/clm_5B0E91B163E1.md) - 2022-04-30 to 2022-07-30 | total_assets | 92,797,000,000 United States dollar | superseded | [clm_610E66853A41](/claim/clm_610E66853A41.md) - 2022-04-30 to 2022-07-30 | cash_and_equivalents | 6,952,000,000 United States dollar | superseded | [clm_7C85CDBABDD4](/claim/clm_7C85CDBABDD4.md) - 2022-04-30 to 2022-10-29 | quarterly_operating_income | 3,610,000,000 United States dollar | superseded | [clm_8971BAC84887](/claim/clm_8971BAC84887.md) - 2022-04-30 to 2022-10-29 | quarterly_revenue | 12,835,000,000 United States dollar | superseded | [clm_E44B6E0260D9](/claim/clm_E44B6E0260D9.md) - 2022-04-30 to 2022-10-29 | quarterly_research_and_development | 1,708,000,000 United States dollar | superseded | [clm_EFB1B3F516CE](/claim/clm_EFB1B3F516CE.md) - 2022-05-19 to 2022-09-02 | shares_outstanding | 4,140,964,037 shares | superseded | [clm_E84780805D34](/claim/clm_E84780805D34.md) - 2022-07-30 to 2022-07-31 | net_income | 11,812,000,000 United States dollar | superseded | [clm_3E00BCAB69E2](/claim/clm_3E00BCAB69E2.md) - 2022-07-30 to 2022-10-29 | total_assets | 94,002,000,000 United States dollar | superseded | [clm_56CF9EE5B2CA](/claim/clm_56CF9EE5B2CA.md) - 2022-07-30 to 2022-07-31 | revenue | 51,557,000,000 United States dollar | superseded | [clm_59B716802513](/claim/clm_59B716802513.md) - 2022-07-30 to 2023-07-29 | research_and_development | 6,774,000,000 United States dollar | superseded | [clm_9D93C2062363](/claim/clm_9D93C2062363.md) - 2022-07-30 to 2022-10-29 | total_equity | 39,773,000,000 United States dollar | superseded | [clm_B230C9E3A5CD](/claim/clm_B230C9E3A5CD.md) - 2022-07-30 to 2022-07-31 | operating_income | 13,969,000,000 United States dollar | superseded | [clm_F318F5E3BA4D](/claim/clm_F318F5E3BA4D.md) - 2022-07-30 to 2022-10-29 | cash_and_equivalents | 7,079,000,000 United States dollar | superseded | [clm_F49D3C1EE9F0](/claim/clm_F49D3C1EE9F0.md) - 2022-07-31 to 2023-07-29 | operating_income | 15,031,000,000 United States dollar | superseded | [clm_2A4E5B4CAA1C](/claim/clm_2A4E5B4CAA1C.md) - 2022-07-31 to 2023-07-29 | net_income | 12,613,000,000 United States dollar | superseded | [clm_5B94F5BC3ED8](/claim/clm_5B94F5BC3ED8.md) - 2022-07-31 to 2022-12-31 | revenue | 56,998,000,000 United States dollar | superseded | [clm_D18CBD8D9D47](/claim/clm_D18CBD8D9D47.md) - 2022-09-02 to 2022-11-17 | shares_outstanding | 4,108,844,167 shares | superseded | [clm_5AAD59AE17C4](/claim/clm_5AAD59AE17C4.md) - 2022-10-29 to 2023-01-28 | quarterly_net_income | 2,670,000,000 United States dollar | superseded | [clm_0E4F6980949D](/claim/clm_0E4F6980949D.md) - 2022-10-29 to 2023-01-28 | quarterly_revenue | 13,632,000,000 United States dollar | superseded | [clm_42B6F52DC1BB](/claim/clm_42B6F52DC1BB.md) - 2022-10-29 to 2023-01-28 | total_assets | 93,054,000,000 United States dollar | superseded | [clm_6A115287942D](/claim/clm_6A115287942D.md) - 2022-10-29 to 2023-01-28 | cash_and_equivalents | 7,292,000,000 United States dollar | superseded | [clm_847CE97EDFD1](/claim/clm_847CE97EDFD1.md) - 2022-10-29 to 2023-01-28 | quarterly_research_and_development | 1,781,000,000 United States dollar | superseded | [clm_90BC753DD86E](/claim/clm_90BC753DD86E.md) - 2022-10-29 to 2023-01-28 | quarterly_operating_income | 3,540,000,000 United States dollar | superseded | [clm_9A075C24CA25](/claim/clm_9A075C24CA25.md) - 2022-10-29 to 2023-01-28 | total_equity | 40,272,000,000 United States dollar | superseded | [clm_BCE4312A501C](/claim/clm_BCE4312A501C.md) - 2022-11-17 to 2023-02-16 | shares_outstanding | 4,108,103,063 shares | superseded | [clm_BF189011E479](/claim/clm_BF189011E479.md) - 2022-12-31 to 2023-07-29 | revenue | 51,557,000,000 United States dollar | superseded | [clm_5941262A5A34](/claim/clm_5941262A5A34.md) ## 2023 - 2023-01-28 to 2023-04-29 | total_equity | 41,474,000,000 United States dollar | superseded | [clm_023BCB8B65CE](/claim/clm_023BCB8B65CE.md) - 2023-01-28 to 2023-04-29 | total_assets | 95,840,000,000 United States dollar | superseded | [clm_0CD6B5980E65](/claim/clm_0CD6B5980E65.md) - 2023-01-28 to 2023-04-29 | quarterly_research_and_development | 1,855,000,000 United States dollar | superseded | [clm_164466BC6A92](/claim/clm_164466BC6A92.md) - 2023-01-28 to 2023-04-29 | quarterly_net_income | 2,773,000,000 United States dollar | superseded | [clm_3EB678CDE150](/claim/clm_3EB678CDE150.md) - 2023-01-28 to 2023-04-29 | quarterly_revenue | 13,592,000,000 United States dollar | superseded | [clm_E0B04C1B5C38](/claim/clm_E0B04C1B5C38.md) - 2023-01-28 to 2023-04-29 | quarterly_operating_income | 3,292,000,000 United States dollar | superseded | [clm_EF4E9024EC22](/claim/clm_EF4E9024EC22.md) - 2023-01-28 to 2023-04-29 | cash_and_equivalents | 9,009,000,000 United States dollar | superseded | [clm_F9DCF1CE7656](/claim/clm_F9DCF1CE7656.md) - 2023-02-16 to 2023-05-18 | shares_outstanding | 4,095,823,317 shares | superseded | [clm_C8255BA665BB](/claim/clm_C8255BA665BB.md) - 2023-04-29 to 2023-10-28 | quarterly_revenue | 14,571,000,000 United States dollar | superseded | [clm_14B0F78FEDC8](/claim/clm_14B0F78FEDC8.md) - 2023-04-29 to 2023-10-28 | quarterly_operating_income | 3,946,000,000 United States dollar | superseded | [clm_2328C5C51CDC](/claim/clm_2328C5C51CDC.md) - 2023-04-29 to 2023-10-28 | quarterly_research_and_development | 1,962,000,000 United States dollar | superseded | [clm_51CD2E3A2E21](/claim/clm_51CD2E3A2E21.md) - 2023-04-29 to 2023-07-29 | cash_and_equivalents | 8,044,000,000 United States dollar | superseded | [clm_59AE8C6D0334](/claim/clm_59AE8C6D0334.md) - 2023-04-29 to 2023-10-28 | quarterly_net_income | 3,212,000,000 United States dollar | superseded | [clm_59E858DC5B67](/claim/clm_59E858DC5B67.md) - 2023-04-29 to 2023-07-29 | total_assets | 97,529,000,000 United States dollar | superseded | [clm_808C47B13740](/claim/clm_808C47B13740.md) - 2023-04-29 to 2023-07-29 | total_equity | 42,295,000,000 United States dollar | superseded | [clm_BA7AD605E571](/claim/clm_BA7AD605E571.md) - 2023-05-18 to 2023-09-01 | shares_outstanding | 4,075,058,155 shares | superseded | [clm_DDE954B7B999](/claim/clm_DDE954B7B999.md) - 2023-07-29 to 2024-07-27 | research_and_development | 7,551,000,000 United States dollar | superseded | [clm_3676181D5730](/claim/clm_3676181D5730.md) - 2023-07-29 to 2023-07-30 | revenue | 56,998,000,000 United States dollar | superseded | [clm_48E5C935DEE8](/claim/clm_48E5C935DEE8.md) - 2023-07-29 to 2023-07-30 | net_income | 12,613,000,000 United States dollar | superseded | [clm_54CCC6851A97](/claim/clm_54CCC6851A97.md) - 2023-07-29 to 2023-10-28 | total_equity | 44,353,000,000 United States dollar | superseded | [clm_78194EE171C4](/claim/clm_78194EE171C4.md) - 2023-07-29 to 2023-07-30 | operating_income | 15,031,000,000 United States dollar | superseded | [clm_8142F1C506B3](/claim/clm_8142F1C506B3.md) - 2023-07-29 to 2023-10-28 | total_assets | 101,852,000,000 United States dollar | superseded | [clm_871FEF668544](/claim/clm_871FEF668544.md) - 2023-07-29 to 2023-10-28 | cash_and_equivalents | 10,123,000,000 United States dollar | superseded | [clm_D26B4610A11D](/claim/clm_D26B4610A11D.md) - 2023-07-30 to 2024-07-27 | operating_income | 12,181,000,000 United States dollar | superseded | [clm_43AFB6CE9C7C](/claim/clm_43AFB6CE9C7C.md) - 2023-07-30 to 2024-07-27 | revenue | 53,803,000,000 United States dollar | superseded | [clm_75A80F40F295](/claim/clm_75A80F40F295.md) - 2023-07-30 to 2024-07-27 | net_income | 10,320,000,000 United States dollar | superseded | [clm_D8251433E33D](/claim/clm_D8251433E33D.md) - 2023-09-01 to 2023-11-16 | shares_outstanding | 4,054,857,783 shares | superseded | [clm_9C1E696322BA](/claim/clm_9C1E696322BA.md) - 2023-10-01 to 2026-05-01 | board_member | Dan Schulman | superseded | [clm_539E5CF8AF48](/claim/clm_539E5CF8AF48.md) - 2023-10-10 | board_member | Daniel H. Schulman | valid | [clm_4343DA75FE21](/claim/clm_4343DA75FE21.md) - 2023-10-28 to 2024-01-27 | cash_and_equivalents | 9,602,000,000 United States dollar | superseded | [clm_32026C6A34B9](/claim/clm_32026C6A34B9.md) - 2023-10-28 to 2024-01-27 | quarterly_revenue | 14,668,000,000 United States dollar | superseded | [clm_3322476E33DB](/claim/clm_3322476E33DB.md) - 2023-10-28 to 2024-01-27 | quarterly_net_income | 3,638,000,000 United States dollar | superseded | [clm_49F2DC4EBD72](/claim/clm_49F2DC4EBD72.md) - 2023-10-28 to 2024-01-27 | total_assets | 98,782,000,000 United States dollar | superseded | [clm_6DBF819FA36D](/claim/clm_6DBF819FA36D.md) - 2023-10-28 to 2024-01-27 | quarterly_operating_income | 4,276,000,000 United States dollar | superseded | [clm_8A8F37ED7B7C](/claim/clm_8A8F37ED7B7C.md) - 2023-10-28 to 2024-01-27 | quarterly_research_and_development | 1,913,000,000 United States dollar | superseded | [clm_9AC320023456](/claim/clm_9AC320023456.md) - 2023-10-28 to 2024-01-27 | total_equity | 45,210,000,000 United States dollar | superseded | [clm_DE4F59F75897](/claim/clm_DE4F59F75897.md) - 2023-11-16 to 2024-02-15 | shares_outstanding | 4,063,475,676 shares | superseded | [clm_60DEC606E1D0](/claim/clm_60DEC606E1D0.md) ## 2024 - 2024-01-27 to 2024-04-27 | cash_and_equivalents | 13,715,000,000 United States dollar | superseded | [clm_1524E4DAAD3C](/claim/clm_1524E4DAAD3C.md) - 2024-01-27 to 2024-04-27 | quarterly_research_and_development | 1,943,000,000 United States dollar | superseded | [clm_41E5329CA721](/claim/clm_41E5329CA721.md) - 2024-01-27 to 2024-04-27 | quarterly_net_income | 2,634,000,000 United States dollar | superseded | [clm_7C7253AB683C](/claim/clm_7C7253AB683C.md) - 2024-01-27 to 2024-04-27 | total_assets | 101,174,000,000 United States dollar | superseded | [clm_7EE26005193B](/claim/clm_7EE26005193B.md) - 2024-01-27 to 2024-04-27 | total_equity | 46,251,000,000 United States dollar | superseded | [clm_A4DEB337A75A](/claim/clm_A4DEB337A75A.md) - 2024-01-27 to 2024-04-27 | quarterly_revenue | 12,791,000,000 United States dollar | superseded | [clm_B035AB710199](/claim/clm_B035AB710199.md) - 2024-01-27 to 2024-04-27 | quarterly_operating_income | 3,096,000,000 United States dollar | superseded | [clm_C7C01479E950](/claim/clm_C7C01479E950.md) - 2024-02-15 to 2024-05-16 | shares_outstanding | 4,049,187,080 shares | superseded | [clm_BC7CBEFB6215](/claim/clm_BC7CBEFB6215.md) - 2024-04-27 to 2024-07-27 | total_equity | 45,768,000,000 United States dollar | superseded | [clm_12C82B840169](/claim/clm_12C82B840169.md) - 2024-04-27 to 2024-10-26 | quarterly_revenue | 12,702,000,000 United States dollar | superseded | [clm_24DE3614BEE1](/claim/clm_24DE3614BEE1.md) - 2024-04-27 to 2024-10-26 | quarterly_operating_income | 2,191,000,000 United States dollar | superseded | [clm_3B61AA6B79E1](/claim/clm_3B61AA6B79E1.md) - 2024-04-27 to 2024-07-27 | cash_and_equivalents | 8,913,000,000 United States dollar | superseded | [clm_41BD9E5FA684](/claim/clm_41BD9E5FA684.md) - 2024-04-27 to 2024-07-27 | total_assets | 122,998,000,000 United States dollar | superseded | [clm_64877D8C65C7](/claim/clm_64877D8C65C7.md) - 2024-04-27 to 2024-10-26 | quarterly_research_and_development | 1,948,000,000 United States dollar | superseded | [clm_E550492204D3](/claim/clm_E550492204D3.md) - 2024-04-27 to 2024-10-26 | quarterly_net_income | 1,886,000,000 United States dollar | superseded | [clm_EC9DF637E053](/claim/clm_EC9DF637E053.md) - 2024-05-15 | president | Gary Steele | valid | [clm_27331FD769A7](/claim/clm_27331FD769A7.md) - 2024-05-16 to 2024-08-30 | shares_outstanding | 4,028,814,776 shares | superseded | [clm_DCE73387CA34](/claim/clm_DCE73387CA34.md) - 2024-06-14 | board_member | Ekta Singh-Bushell | valid | [clm_387A063E80A0](/claim/clm_387A063E80A0.md) - 2024-07-27 to 2024-10-26 | cash_and_equivalents | 7,508,000,000 United States dollar | superseded | [clm_3ACF852DDBCF](/claim/clm_3ACF852DDBCF.md) - 2024-07-27 to 2025-07-26 | research_and_development | 7,983,000,000 United States dollar | superseded | [clm_76B25036B4FD](/claim/clm_76B25036B4FD.md) - 2024-07-27 to 2024-10-26 | total_equity | 45,457,000,000 United States dollar | superseded | [clm_8D29CBE819DF](/claim/clm_8D29CBE819DF.md) - 2024-07-27 to 2024-10-26 | total_assets | 124,413,000,000 United States dollar | superseded | [clm_9425538F4C29](/claim/clm_9425538F4C29.md) - 2024-07-27 to 2024-07-28 | net_income | 10,320,000,000 United States dollar | superseded | [clm_9D3566E9E4D0](/claim/clm_9D3566E9E4D0.md) - 2024-07-27 to 2024-07-28 | operating_income | 12,181,000,000 United States dollar | superseded | [clm_A6FFB431E4C5](/claim/clm_A6FFB431E4C5.md) - 2024-07-27 to 2024-07-28 | revenue | 53,803,000,000 United States dollar | superseded | [clm_E163F8221BBC](/claim/clm_E163F8221BBC.md) - 2024-07-28 to 2025-07-26 | net_income | 10,180,000,000 United States dollar | superseded | [clm_C06B15821A37](/claim/clm_C06B15821A37.md) - 2024-07-28 to 2025-07-26 | revenue | 56,654,000,000 United States dollar | superseded | [clm_F20473713F97](/claim/clm_F20473713F97.md) - 2024-07-28 to 2025-07-26 | operating_income | 11,760,000,000 United States dollar | superseded | [clm_F32CBABE36DA](/claim/clm_F32CBABE36DA.md) - 2024-08-30 to 2024-11-14 | shares_outstanding | 3,990,734,794 shares | superseded | [clm_0EFA22765F75](/claim/clm_0EFA22765F75.md) - 2024-08-30 | owned_by | The Vanguard Group | valid | [clm_EA9AA6BC90C9](/claim/clm_EA9AA6BC90C9.md) - 2024-08-30 | owned_by | BlackRock | valid | [clm_FE7C916A26A2](/claim/clm_FE7C916A26A2.md) - 2024-10-26 to 2025-01-25 | total_assets | 123,333,000,000 United States dollar | superseded | [clm_34DA2A06376E](/claim/clm_34DA2A06376E.md) - 2024-10-26 to 2025-01-25 | quarterly_net_income | 2,711,000,000 United States dollar | superseded | [clm_58677B856A09](/claim/clm_58677B856A09.md) - 2024-10-26 to 2025-01-25 | quarterly_revenue | 13,841,000,000 United States dollar | superseded | [clm_8A28BC0F768B](/claim/clm_8A28BC0F768B.md) - 2024-10-26 to 2025-01-25 | quarterly_operating_income | 2,358,000,000 United States dollar | superseded | [clm_9E29FB2A09A9](/claim/clm_9E29FB2A09A9.md) - 2024-10-26 to 2025-01-25 | quarterly_research_and_development | 2,286,000,000 United States dollar | superseded | [clm_B861749C3484](/claim/clm_B861749C3484.md) - 2024-10-26 to 2025-01-25 | total_equity | 45,277,000,000 United States dollar | superseded | [clm_E5F0BFA72881](/claim/clm_E5F0BFA72881.md) - 2024-10-26 to 2025-01-25 | cash_and_equivalents | 9,065,000,000 United States dollar | superseded | [clm_F3B2FA9EA052](/claim/clm_F3B2FA9EA052.md) - 2024-11-14 to 2025-02-13 | shares_outstanding | 3,982,758,260 shares | superseded | [clm_8D179FA8B599](/claim/clm_8D179FA8B599.md) ## 2025 - 2025-01-25 to 2025-04-26 | total_equity | 45,530,000,000 United States dollar | superseded | [clm_2D51A567FC2C](/claim/clm_2D51A567FC2C.md) - 2025-01-25 to 2025-04-26 | quarterly_operating_income | 3,113,000,000 United States dollar | superseded | [clm_59BA6B48A4CC](/claim/clm_59BA6B48A4CC.md) - 2025-01-25 to 2025-04-26 | quarterly_research_and_development | 2,299,000,000 United States dollar | superseded | [clm_61CA589A2C6F](/claim/clm_61CA589A2C6F.md) - 2025-01-25 to 2025-04-26 | quarterly_net_income | 2,428,000,000 United States dollar | superseded | [clm_8907C3114594](/claim/clm_8907C3114594.md) - 2025-01-25 to 2025-04-26 | total_assets | 121,375,000,000 United States dollar | superseded | [clm_BB2F14D6DAB4](/claim/clm_BB2F14D6DAB4.md) - 2025-01-25 to 2025-04-26 | quarterly_revenue | 13,991,000,000 United States dollar | superseded | [clm_EBAB61E91B3A](/claim/clm_EBAB61E91B3A.md) - 2025-01-25 to 2025-04-26 | cash_and_equivalents | 8,556,000,000 United States dollar | superseded | [clm_F17C0C0F77A0](/claim/clm_F17C0C0F77A0.md) - 2025-02-13 to 2025-05-15 | shares_outstanding | 3,978,292,432 shares | superseded | [clm_909823A509A7](/claim/clm_909823A509A7.md) - 2025-04-26 to 2025-10-25 | quarterly_operating_income | 3,202,000,000 United States dollar | superseded | [clm_1DC5EF1F7AFF](/claim/clm_1DC5EF1F7AFF.md) - 2025-04-26 to 2025-07-26 | cash_and_equivalents | 8,161,000,000 United States dollar | superseded | [clm_5BD371F0B200](/claim/clm_5BD371F0B200.md) - 2025-04-26 to 2025-07-26 | total_equity | 45,935,000,000 United States dollar | superseded | [clm_72BA20E72BEC](/claim/clm_72BA20E72BEC.md) - 2025-04-26 to 2025-07-26 | total_assets | 119,782,000,000 United States dollar | superseded | [clm_7E924EDA55D2](/claim/clm_7E924EDA55D2.md) - 2025-04-26 to 2025-10-25 | quarterly_research_and_development | 2,335,000,000 United States dollar | superseded | [clm_C3149CE6F9B5](/claim/clm_C3149CE6F9B5.md) - 2025-04-26 to 2025-10-25 | quarterly_revenue | 14,149,000,000 United States dollar | superseded | [clm_CC3D3DDB5A38](/claim/clm_CC3D3DDB5A38.md) - 2025-04-26 to 2025-10-25 | quarterly_net_income | 2,491,000,000 United States dollar | superseded | [clm_DE337F67B32D](/claim/clm_DE337F67B32D.md) - 2025-05-12 | board_member | Kevin Weil | valid | [clm_9583F76D5DF2](/claim/clm_9583F76D5DF2.md) - 2025-05-14 | president | Jeetu Patel | valid | [clm_45E2211F780F](/claim/clm_45E2211F780F.md) - 2025-05-15 to 2025-08-28 | shares_outstanding | 3,959,998,180 shares | superseded | [clm_196C1C35480A](/claim/clm_196C1C35480A.md) - 2025-07-26 to 2026-07-25 | revenue | 56,654,000,000 United States dollar | superseded | [clm_804C64300B89](/claim/clm_804C64300B89.md) - 2025-07-26 to 2026-07-25 | employees | 86,200 | superseded | [clm_9B487D312F8D](/claim/clm_9B487D312F8D.md) - 2025-07-26 to 2026-07-25 | operating_income | 11,760,000,000 United States dollar | superseded | [clm_AB043A37AF82](/claim/clm_AB043A37AF82.md) - 2025-07-26 to 2026-07-25 | net_income | 10,180,000,000 United States dollar | superseded | [clm_C91E244500C1](/claim/clm_C91E244500C1.md) - 2025-07-26 to 2025-10-25 | total_assets | 122,291,000,000 United States dollar | superseded | [clm_D310A7C3A71E](/claim/clm_D310A7C3A71E.md) - 2025-07-26 to 2025-10-25 | total_equity | 46,843,000,000 United States dollar | superseded | [clm_D537DD639037](/claim/clm_D537DD639037.md) - 2025-07-26 to 2026-07-25 | research_and_development | 9,300,000,000 United States dollar | superseded | [clm_F1710941FFC6](/claim/clm_F1710941FFC6.md) - 2025-07-26 to 2025-10-25 | cash_and_equivalents | 8,346,000,000 United States dollar | superseded | [clm_FF95E28EAB99](/claim/clm_FF95E28EAB99.md) - 2025-07-27 | cfo | Mark Patterson | valid | [clm_97A9EDE47D4B](/claim/clm_97A9EDE47D4B.md) - 2025-08-28 to 2025-11-13 | shares_outstanding | 3,953,196,953 shares | superseded | [clm_043A42443F56](/claim/clm_043A42443F56.md) - 2025-10-25 to 2026-01-24 | total_assets | 121,102,000,000 United States dollar | superseded | [clm_1C1A4AAAB120](/claim/clm_1C1A4AAAB120.md) - 2025-10-25 to 2026-01-24 | total_equity | 46,873,000,000 United States dollar | superseded | [clm_5344C878BE88](/claim/clm_5344C878BE88.md) - 2025-10-25 to 2026-01-24 | quarterly_operating_income | 3,363,000,000 United States dollar | superseded | [clm_754D78098E5A](/claim/clm_754D78098E5A.md) - 2025-10-25 to 2026-01-24 | cash_and_equivalents | 8,400,000,000 United States dollar | superseded | [clm_B6460E75F5F1](/claim/clm_B6460E75F5F1.md) - 2025-10-25 to 2026-01-24 | quarterly_revenue | 14,883,000,000 United States dollar | superseded | [clm_C5AD3A7A4BC6](/claim/clm_C5AD3A7A4BC6.md) - 2025-10-25 to 2026-01-24 | quarterly_net_income | 2,860,000,000 United States dollar | superseded | [clm_CE3FDB785CC9](/claim/clm_CE3FDB785CC9.md) - 2025-10-25 to 2026-01-24 | quarterly_research_and_development | 2,400,000,000 United States dollar | superseded | [clm_E64349EBBFB3](/claim/clm_E64349EBBFB3.md) - 2025-11-13 to 2026-02-12 | shares_outstanding | 3,951,094,563 shares | superseded | [clm_DB683E0D552E](/claim/clm_DB683E0D552E.md) ## 2026 - 2026-01-24 to 2026-04-25 | cash_and_equivalents | 7,458,000,000 United States dollar | superseded | [clm_0846178BB242](/claim/clm_0846178BB242.md) - 2026-01-24 to 2026-04-25 | quarterly_research_and_development | 2,355,000,000 United States dollar | superseded | [clm_2FE1B14A7341](/claim/clm_2FE1B14A7341.md) - 2026-01-24 to 2026-04-25 | total_equity | 47,723,000,000 United States dollar | superseded | [clm_607C3BBFE3BE](/claim/clm_607C3BBFE3BE.md) - 2026-01-24 to 2026-04-25 | quarterly_revenue | 15,349,000,000 United States dollar | superseded | [clm_63A9441A5724](/claim/clm_63A9441A5724.md) - 2026-01-24 to 2026-04-25 | quarterly_operating_income | 3,781,000,000 United States dollar | superseded | [clm_70154D10E64D](/claim/clm_70154D10E64D.md) - 2026-01-24 to 2026-04-25 | quarterly_net_income | 3,175,000,000 United States dollar | superseded | [clm_7D2460561432](/claim/clm_7D2460561432.md) - 2026-01-24 to 2026-04-25 | total_assets | 123,371,000,000 United States dollar | superseded | [clm_F1722A7977D9](/claim/clm_F1722A7977D9.md) - 2026-02-12 to 2026-05-14 | shares_outstanding | 3,949,893,042 shares | superseded | [clm_F67B958A7E01](/claim/clm_F67B958A7E01.md) - 2026-04-06 | board_member | Peter A. Shimer | valid | [clm_CA13FC5CBDD5](/claim/clm_CA13FC5CBDD5.md) - 2026-04-25 | quarterly_net_income | 3,373,000,000 United States dollar | valid | [clm_4689D32FC137](/claim/clm_4689D32FC137.md) - 2026-04-25 | quarterly_research_and_development | 2,377,000,000 United States dollar | valid | [clm_6EC96C2569EB](/claim/clm_6EC96C2569EB.md) - 2026-04-25 to 2026-07-25 | cash_and_equivalents | 7,083,000,000 United States dollar | superseded | [clm_76FCDF9E5FDD](/claim/clm_76FCDF9E5FDD.md) - 2026-04-25 to 2026-07-25 | total_equity | 48,861,000,000 United States dollar | superseded | [clm_9960C5284FCF](/claim/clm_9960C5284FCF.md) - 2026-04-25 | quarterly_revenue | 15,841,000,000 United States dollar | valid | [clm_A06F8D500237](/claim/clm_A06F8D500237.md) - 2026-04-25 to 2026-07-25 | total_assets | 125,546,000,000 United States dollar | superseded | [clm_A784F66AA105](/claim/clm_A784F66AA105.md) - 2026-04-25 | quarterly_operating_income | 3,960,000,000 United States dollar | valid | [clm_D731B0F4F1A1](/claim/clm_D731B0F4F1A1.md) - 2026-05-05 to 2026-10-28 | market_cap | 393,380,000,000 United States dollar | superseded | [clm_4960683B99C0](/claim/clm_4960683B99C0.md) - 2026-05-13 | restructuring | Restructuring to invest in silicon, optics, security and AI growth. | valid | [clm_1D0A7FCD6420](/claim/clm_1D0A7FCD6420.md) - 2026-05-14 to 2026-08-27 | shares_outstanding | 3,941,434,665 shares | superseded | [clm_D014FA83DCB8](/claim/clm_D014FA83DCB8.md) - 2026-07-25 | net_income | 13,267,000,000 United States dollar | valid | [clm_33AF1B01F222](/claim/clm_33AF1B01F222.md) - 2026-07-25 | total_assets | 129,637,000,000 United States dollar | valid | [clm_3A794C595CB5](/claim/clm_3A794C595CB5.md) - 2026-07-25 | cash_and_equivalents | 7,218,000,000 United States dollar | valid | [clm_5E75F4F2867D](/claim/clm_5E75F4F2867D.md) - 2026-07-25 | employees | 82,400 | valid | [clm_6A8D726B4AA8](/claim/clm_6A8D726B4AA8.md) - 2026-07-25 | research_and_development | 9,563,000,000 United States dollar | valid | [clm_9397A0628097](/claim/clm_9397A0628097.md) - 2026-07-25 | operating_income | 15,368,000,000 United States dollar | valid | [clm_9C73609CF130](/claim/clm_9C73609CF130.md) - 2026-07-25 | total_equity | 50,285,000,000 United States dollar | valid | [clm_9ED742DD2951](/claim/clm_9ED742DD2951.md) - 2026-07-25 | revenue | 63,325,000,000 United States dollar | valid | [clm_D05F971F1E27](/claim/clm_D05F971F1E27.md) - 2026-08-27 | shares_outstanding | 3,942,586,873 shares | valid | [clm_4411A2788F27](/claim/clm_4411A2788F27.md) - 2026-10-09 | board_member | Girish D. Rishi | valid | [clm_2AAF38639DFE](/claim/clm_2AAF38639DFE.md) - 2026-10-28 | market_cap | 439,610,000,000 United States dollar | unverified | [clm_66D2E502B82F](/claim/clm_66D2E502B82F.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.